<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1155" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1155/" /><meta name="ncbi_pagename" content="Hereditary Dystonia Overview - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Hereditary Dystonia Overview - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Hereditary Dystonia Overview" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/06/22" /><meta name="citation_author" content="Christine Klein" /><meta name="citation_author" content="Katja Lohmann" /><meta name="citation_author" content="Connie Marras" /><meta name="citation_author" content="Alexander Münchau" /><meta name="citation_pmid" content="20301334" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1155/" /><meta name="citation_keywords" content="85/88 kDa calcium-independent phospholipase A2" /><meta name="citation_keywords" content="Arylsulfatase A" /><meta name="citation_keywords" content="Atrophin-1" /><meta name="citation_keywords" content="Battenin" /><meta name="citation_keywords" content="Beta-galactosidase" /><meta name="citation_keywords" content="Biotinidase" /><meta name="citation_keywords" content="BTB/POZ domain-containing protein KCTD7" /><meta name="citation_keywords" content="Cathepsin D" /><meta name="citation_keywords" content="Cathepsin F" /><meta name="citation_keywords" content="Cation-transporting ATPase 13A2" /><meta name="citation_keywords" content="Ceroid-lipofuscinosis neuronal protein 5" /><meta name="citation_keywords" content="Ceroid-lipofuscinosis neuronal protein 6" /><meta name="citation_keywords" content="Ceruloplasmin" /><meta name="citation_keywords" content="Copper-transporting ATPase 2" /><meta name="citation_keywords" content="Corrinoid adenosyltransferase" /><meta name="citation_keywords" content="Cystathionine beta-synthase" /><meta name="citation_keywords" content="D-2-hydroxyglutarate dehydrogenase, mitochondrial" /><meta name="citation_keywords" content="DDB1- and CUL4-associated factor 17" /><meta name="citation_keywords" content="Deoxynucleoside triphosphate triphosphohydrolase SAMHD1" /><meta name="citation_keywords" content="DNA polymerase subunit gamma-1" /><meta name="citation_keywords" content="DnaJ homolog subfamily C member 5" /><meta name="citation_keywords" content="Double-stranded RNA-specific adenosine deaminase" /><meta name="citation_keywords" content="E3 ubiquitin-protein ligase parkin" /><meta name="citation_keywords" content="Epsilon-sarcoglycan" /><meta name="citation_keywords" content="Fatty acid 2-hydroxylase" /><meta name="citation_keywords" content="Ferritin light chain" /><meta name="citation_keywords" content="Galactocerebrosidase" /><meta name="citation_keywords" content="Galactose-1-phosphate uridylyltransferase" /><meta name="citation_keywords" content="Ganglioside GM2 activator" /><meta name="citation_keywords" content="Glutaryl-CoA dehydrogenase, mitochondrial" /><meta name="citation_keywords" content="Glycine amidinotransferase, mitochondrial" /><meta name="citation_keywords" content="GTP cyclohydrolase 1" /><meta name="citation_keywords" content="Guanidinoacetate N-methyltransferase" /><meta name="citation_keywords" content="Guanine nucleotide-binding protein G(olf) subunit alpha" /><meta name="citation_keywords" content="Huntingtin" /><meta name="citation_keywords" content="Hypoxanthine-guanine phosphoribosyltransferase" /><meta name="citation_keywords" content="Junctophilin-3" /><meta name="citation_keywords" content="Major facilitator superfamily domain-containing protein 8" /><meta name="citation_keywords" content="Membrane transport protein XK" /><meta name="citation_keywords" content="Methyl-CpG-binding protein 2" /><meta name="citation_keywords" content="Methylmalonic aciduria and homocystinuria type D protein, mitochondrial" /><meta name="citation_keywords" content="Methylmalonic aciduria type A protein, mitochondrial" /><meta name="citation_keywords" content="Methylmalonyl-CoA epimerase, mitochondrial" /><meta name="citation_keywords" content="Methylmalonyl-CoA mutase, mitochondrial" /><meta name="citation_keywords" content="Mitochondrial import inner membrane translocase subunit Tim8 A" /><meta name="citation_keywords" content="Myelin proteolipid protein" /><meta name="citation_keywords" content="NPC intracellular cholesterol transporter 1" /><meta name="citation_keywords" content="NPC intracellular cholesterol transporter 2" /><meta name="citation_keywords" content="Palmitoyl-protein thioesterase 1" /><meta name="citation_keywords" content="Pantothenate kinase 2, mitochondrial" /><meta name="citation_keywords" content="Phenylalanine-4-hydroxylase" /><meta name="citation_keywords" content="Platelet-derived growth factor receptor beta" /><meta name="citation_keywords" content="Platelet-derived growth factor subunit B" /><meta name="citation_keywords" content="Probable hydrolase PNKD" /><meta name="citation_keywords" content="Progranulin" /><meta name="citation_keywords" content="Proline-rich transmembrane protein 2" /><meta name="citation_keywords" content="Protein C19orf12" /><meta name="citation_keywords" content="Protein CLN8" /><meta name="citation_keywords" content="Ribonuclease H2 subunit A" /><meta name="citation_keywords" content="Ribonuclease H2 subunit B" /><meta name="citation_keywords" content="Ribonuclease H2 subunit C" /><meta name="citation_keywords" content="Sepiapterin reductase" /><meta name="citation_keywords" content="Sodium- and chloride-dependent creatine transporter 1" /><meta name="citation_keywords" content="Sodium/potassium-transporting ATPase subunit alpha-3" /><meta name="citation_keywords" content="Sodium-dependent neutral amino acid transporter B(0)AT1" /><meta name="citation_keywords" content="Sodium-dependent phosphate transporter 2" /><meta name="citation_keywords" content="Solute carrier family 2, facilitated glucose transporter member 1" /><meta name="citation_keywords" content="THAP domain-containing protein 1" /><meta name="citation_keywords" content="Thiamine transporter 2" /><meta name="citation_keywords" content="Three prime repair exonuclease 1" /><meta name="citation_keywords" content="Tissue alpha-L-fucosidase" /><meta name="citation_keywords" content="Torsin-1A" /><meta name="citation_keywords" content="Transcription initiation factor TFIID subunit 1" /><meta name="citation_keywords" content="Tripeptidyl-peptidase 1" /><meta name="citation_keywords" content="Tyrosine 3-monooxygenase" /><meta name="citation_keywords" content="Vacuolar protein sorting-associated protein 13A" /><meta name="citation_keywords" content="WD repeat domain phosphoinositide-interacting protein 4" /><meta name="citation_keywords" content="Zinc transporter 10" /><meta name="citation_keywords" content="ADAR" /><meta name="citation_keywords" content="ARSA" /><meta name="citation_keywords" content="ATN1" /><meta name="citation_keywords" content="ATP13A2" /><meta name="citation_keywords" content="ATP1A3" /><meta name="citation_keywords" content="ATP7B" /><meta name="citation_keywords" content="BTD" /><meta name="citation_keywords" content="C19orf12" /><meta name="citation_keywords" content="CBS" /><meta name="citation_keywords" content="CLN3" /><meta name="citation_keywords" content="CLN5" /><meta name="citation_keywords" content="CLN6" /><meta name="citation_keywords" content="CLN8" /><meta name="citation_keywords" content="CP" /><meta name="citation_keywords" content="CTSD" /><meta name="citation_keywords" content="CTSF" /><meta name="citation_keywords" content="D2HGDH" /><meta name="citation_keywords" content="DCAF17" /><meta name="citation_keywords" content="DNAJC5" /><meta name="citation_keywords" content="FA2H" /><meta name="citation_keywords" content="FTL" /><meta name="citation_keywords" content="FUCA1" /><meta name="citation_keywords" content="GALC" /><meta name="citation_keywords" content="GALT" /><meta name="citation_keywords" content="GAMT" /><meta name="citation_keywords" content="GATM" /><meta name="citation_keywords" content="GCDH" /><meta name="citation_keywords" content="GCH1" /><meta name="citation_keywords" content="GLB1" /><meta name="citation_keywords" content="GM2A" /><meta name="citation_keywords" content="GNAL" /><meta name="citation_keywords" content="GRN" /><meta name="citation_keywords" content="HPRT1" /><meta name="citation_keywords" content="HTT" /><meta name="citation_keywords" content="JPH3" /><meta name="citation_keywords" content="KCTD7" /><meta name="citation_keywords" content="MCEE" /><meta name="citation_keywords" content="MECP2" /><meta name="citation_keywords" content="MFSD8" /><meta name="citation_keywords" content="MMAA" /><meta name="citation_keywords" content="MMAB" /><meta name="citation_keywords" content="MMADHC" /><meta name="citation_keywords" content="MMUT" /><meta name="citation_keywords" content="NPC1" /><meta name="citation_keywords" content="NPC2" /><meta name="citation_keywords" content="PAH" /><meta name="citation_keywords" content="PANK2" /><meta name="citation_keywords" content="PDGFB" /><meta name="citation_keywords" content="PDGFRB" /><meta name="citation_keywords" content="PLA2G6" /><meta name="citation_keywords" content="PLP1" /><meta name="citation_keywords" content="PNKD" /><meta name="citation_keywords" content="POLG" /><meta name="citation_keywords" content="PPT1" /><meta name="citation_keywords" content="PRKN" /><meta name="citation_keywords" content="PRRT2" /><meta name="citation_keywords" content="RNASEH2A" /><meta name="citation_keywords" content="RNASEH2B" /><meta name="citation_keywords" content="RNASEH2C" /><meta name="citation_keywords" content="SAMHD1" /><meta name="citation_keywords" content="SGCE" /><meta name="citation_keywords" content="SLC19A3" /><meta name="citation_keywords" content="SLC20A2" /><meta name="citation_keywords" content="SLC2A1" /><meta name="citation_keywords" content="SLC30A10" /><meta name="citation_keywords" content="SLC6A19" /><meta name="citation_keywords" content="SLC6A8" /><meta name="citation_keywords" content="SPR" /><meta name="citation_keywords" content="TAF1" /><meta name="citation_keywords" content="TH" /><meta name="citation_keywords" content="THAP1" /><meta name="citation_keywords" content="TIMM8A" /><meta name="citation_keywords" content="TOR1A" /><meta name="citation_keywords" content="TPP1" /><meta name="citation_keywords" content="TREX1" /><meta name="citation_keywords" content="VPS13A" /><meta name="citation_keywords" content="WDR45" /><meta name="citation_keywords" content="XK" /><meta name="citation_keywords" content="Hereditary Dystonia" /><meta name="citation_keywords" content="Overview" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Hereditary Dystonia Overview" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Christine Klein" /><meta name="DC.Contributor" content="Katja Lohmann" /><meta name="DC.Contributor" content="Connie Marras" /><meta name="DC.Contributor" content="Alexander Münchau" /><meta name="DC.Date" content="2017/06/22" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1155/" /><meta name="description" content="The purpose of this overview on hereditary dystonia is to help clinicians determine if an individual has a hereditary dystonia in order to provide information regarding recurrence risk and evaluation of relatives at risk." /><meta name="og:title" content="Hereditary Dystonia Overview" /><meta name="og:type" content="book" /><meta name="og:description" content="The purpose of this overview on hereditary dystonia is to help clinicians determine if an individual has a hereditary dystonia in order to provide information regarding recurrence risk and evaluation of relatives at risk." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1155/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/dystonia-ov/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1155/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8802A3E04150510000000000D20057.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1155_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1155_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/hered-drta/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/hfpoik-tmp/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1155_"><span class="title" itemprop="name">Hereditary Dystonia Overview</span></h1><p class="contrib-group"><span itemprop="author">Christine Klein</span>, MD, <span itemprop="author">Katja Lohmann</span>, PhD, <span itemprop="author">Connie Marras</span>, MD, PhD, and <span itemprop="author">Alexander M&#x000fc;nchau</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1155_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1155_ai__"><div class="contrib half_rhythm"><span itemprop="author">Christine Klein</span>, MD<div class="affiliation small">Institute of Neurogenetics and Department of Neurology<br />University of L&#x000fc;beck<br />L&#x000fc;beck, Germany<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.kcebeul-inu.oruen@nielk.enitsirhc" class="oemail">ed.kcebeul-inu.oruen@nielk.enitsirhc</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Katja Lohmann</span>, PhD<div class="affiliation small">Institute of Neurogenetics<br />University of L&#x000fc;beck<br />L&#x000fc;beck, Germany<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.kcebeul-inu.oruen@nnamhol.ajtak" class="oemail">ed.kcebeul-inu.oruen@nnamhol.ajtak</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Connie Marras</span>, MD, PhD<div class="affiliation small">Movement Disorders Centre<br />Toronto Western Hospital<br />University of Toronto<br />Toronto, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.hcraesernhu@sarramc" class="oemail">ac.hcraesernhu@sarramc</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Alexander M&#x000fc;nchau</span>, MD<div class="affiliation small">Institute of Neurogenetics and Department of Neurology<br />University of L&#x000fc;beck<br />L&#x000fc;beck, Germany<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.kcebeul-inu.oruen@uahcneum.rednaxela" class="oemail">ed.kcebeul-inu.oruen@uahcneum.rednaxela</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 28, 2003</span>; Last Update: <span itemprop="dateModified">June 22, 2017</span>.</p><p><em>Estimated reading time: 31 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="dystonia-ov.Summary" itemprop="description"><h2 id="_dystonia-ov_Summary_">Summary</h2><p>The purpose of this overview on hereditary dystonia is to help clinicians determine if an individual has a hereditary dystonia in order to provide information regarding <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> and evaluation of relatives at risk.</p><div><h4 class="inline">Goal 1.</h4><p>Describe the <a href="#dystonia-ov.Clinical_Characteristics_of">clinical characteristics</a> of dystonia.</p></div><div><h4 class="inline">Goal 2.</h4><p>Review the <a href="#dystonia-ov.Causes_of_Hereditary_Dystoni">causes</a> of hereditary dystonia.</p></div><div><h4 class="inline">Goal 3.</h4><p>Provide an <a href="#dystonia-ov.Evaluation_Strategy">evaluation strategy</a> to determine the etiology of hereditary dystonia in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</p></div><div><h4 class="inline">Goal 4.</h4><p>Review the <a href="#dystonia-ov.NonGenetic_Causes_of_Dystoni">differential diagnosis</a> of hereditary dystonia (i.e., non-genetic causes of dystonia).</p></div><div><h4 class="inline">Goal 5.</h4><p>Provide information regarding <a href="#dystonia-ov.Genetic_Counseling">recurrence risk and evaluation of relatives of a proband</a> with hereditary dystonia who are at risk.</p></div></div><div id="dystonia-ov.Clinical_Characteristics_of"><h2 id="_dystonia-ov_Clinical_Characteristics_of_">Clinical Characteristics of Dystonia</h2><p>Dystonia is a movement disorder characterized by sustained or intermittent muscle contractions causing abnormal, often repetitive movements and/or postures. Dystonic movements are typically patterned and twisting, and may be associated with tremor. Dystonia is often initiated or worsened by voluntary action and associated with overflow muscle activation. Most forms of dystonia tend to worsen initially. Forms of dystonia without neurodegeneration usually reach a plateau with stable findings, whereas those associated with neuronal loss progressively worsen over time.</p><p>Dystonia can be classified clinically according to age of onset, body distribution (see <a class="figpopup" href="/books/NBK1155/table/dystonia-ov.T.classification_of_dystonia/?report=objectonly" target="object" rid-figpopup="figdystoniaovTclassificationofdystonia" rid-ob="figobdystoniaovTclassificationofdystonia">Table 1</a>), temporal pattern, and associated features.</p><p><b>Age of onset</b></p><ul><li class="half_rhythm"><div>Infancy (neonatal &#x02013; 2 years)</div></li><li class="half_rhythm"><div>Childhood (3-12 years)</div></li><li class="half_rhythm"><div>Adolescence (13-20 years)</div></li><li class="half_rhythm"><div>Early adulthood (21-40 years)</div></li><li class="half_rhythm"><div>Late adulthood (&#x0003e;40 years)</div></li></ul><p><b>Body distribution.</b> See <a class="figpopup" href="/books/NBK1155/table/dystonia-ov.T.classification_of_dystonia/?report=objectonly" target="object" rid-figpopup="figdystoniaovTclassificationofdystonia" rid-ob="figobdystoniaovTclassificationofdystonia">Table 1</a>.</p><div id="dystonia-ov.T.classification_of_dystonia" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Classification of Dystonias by Affected Body Part</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1155/table/dystonia-ov.T.classification_of_dystonia/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__dystonia-ov.T.classification_of_dystonia_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_dystonia-ov.T.classification_of_dystonia_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Type of Dystonia</th><th id="hd_h_dystonia-ov.T.classification_of_dystonia_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"># of Body Parts Affected</th><th id="hd_h_dystonia-ov.T.classification_of_dystonia_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Detail</th></tr></thead><tbody><tr><td headers="hd_h_dystonia-ov.T.classification_of_dystonia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Focal&#x000a0;<sup>1</sup></b></td><td headers="hd_h_dystonia-ov.T.classification_of_dystonia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1</td><td headers="hd_h_dystonia-ov.T.classification_of_dystonia_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Examples:
<ul><li class="half_rhythm"><div>Eyelids (blepharospasm)</div></li><li class="half_rhythm"><div>Mouth (oromandibular dystonia, musician's cramp)</div></li><li class="half_rhythm"><div>Larynx (dystonic adductor dysphonia, "whispering dysphonia")</div></li><li class="half_rhythm"><div>Neck (cervical dystonia, previously known as spasmodic torticollis)</div></li><li class="half_rhythm"><div>Hand &#x00026; arm (writer's cramp)</div></li></ul>
</td></tr><tr><td headers="hd_h_dystonia-ov.T.classification_of_dystonia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Segmental</b></td><td headers="hd_h_dystonia-ov.T.classification_of_dystonia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02265;2 contiguous body parts</td><td headers="hd_h_dystonia-ov.T.classification_of_dystonia_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Examples:
<ul><li class="half_rhythm"><div>Axial (neck &#x00026; trunk)</div></li><li class="half_rhythm"><div>Brachial (1 arm &#x00026; trunk; both arms &#x000b1; neck &#x000b1; trunk)</div></li><li class="half_rhythm"><div>Crural (1 leg &#x00026; trunk; both legs &#x000b1; trunk)</div></li></ul>
</td></tr><tr><td headers="hd_h_dystonia-ov.T.classification_of_dystonia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Multifocal</b></td><td headers="hd_h_dystonia-ov.T.classification_of_dystonia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02265;2 non-contiguous body parts</td><td headers="hd_h_dystonia-ov.T.classification_of_dystonia_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Example:
<ul><li class="half_rhythm"><div>Faciobrachial (blepharospasm &#x00026; writer's cramp)</div></li></ul>
</td></tr><tr><td headers="hd_h_dystonia-ov.T.classification_of_dystonia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hemidystonia</b></td><td headers="hd_h_dystonia-ov.T.classification_of_dystonia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02265;2</td><td headers="hd_h_dystonia-ov.T.classification_of_dystonia_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ipsilateral arm &#x00026; leg</td></tr><tr><td headers="hd_h_dystonia-ov.T.classification_of_dystonia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Generalized</b></td><td headers="hd_h_dystonia-ov.T.classification_of_dystonia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02265;3</td><td headers="hd_h_dystonia-ov.T.classification_of_dystonia_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Trunk &#x00026; &#x02265;2 other sites; &#x000b1; leg involvement</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="dystonia-ov.TF.1.1"><p class="no_margin">Some localized dystonias may spread and eventually generalize.</p></div></dd></dl></div></div></div><p><b>Temporal pattern</b></p><ul><li class="half_rhythm"><div>Persistent. Dystonia persists to about the same extent throughout the day.</div></li><li class="half_rhythm"><div>Action-specific (e.g., musician's dystonia, writer's cramp)</div></li><li class="half_rhythm"><div>Diurnal fluctuations (e.g., dopa-responsive dystonia)</div></li><li class="half_rhythm"><div>Paroxysmal. Dystonia/dyskinesia appear suddenly and are self-limited, usually induced by a specific trigger.</div></li></ul><p><b>Classification of dystonias by associated features</b></p><ul><li class="half_rhythm"><div>Isolated dystonia. Dystonia is the only motor feature with the exception of possible tremor (see <a class="figpopup" href="/books/NBK1155/table/dystonia-ov.T.nomenclature_system_for_in/?report=objectonly" target="object" rid-figpopup="figdystoniaovTnomenclaturesystemforin" rid-ob="figobdystoniaovTnomenclaturesystemforin">Table 3</a>).</div></li><li class="half_rhythm"><div>Combined dystonia. Dystonia is combined with another movement disorder (e.g., myoclonus, parkinsonism) (see <a class="figpopup" href="/books/NBK1155/table/dystonia-ov.T.nomenclature_system_for_in/?report=objectonly" target="object" rid-figpopup="figdystoniaovTnomenclaturesystemforin" rid-ob="figobdystoniaovTnomenclaturesystemforin">Table 3</a>).</div></li><li class="half_rhythm"><div>Complex dystonia. Dystonia co-occurs with other neurologic or systemic manifestations; dystonia is not necessarily the most prominent disease manifestation and may even be an inconsistent feature (see <a class="figpopup" href="/books/NBK1155/table/dystonia-ov.T.complex_dystonias_inherite/?report=objectonly" target="object" rid-figpopup="figdystoniaovTcomplexdystoniasinherite" rid-ob="figobdystoniaovTcomplexdystoniasinherite">Table 4</a>).</div></li></ul><p>When dystonic movements are the presenting or predominant sign, the class of dystonia (i.e., <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a>, combined, or complex) may be difficult to identify. Whereas gradual-onset focal or segmental dystonia can be classified as isolated in the vast majority of adult-onset dystonia, this is true for fewer than half of those with childhood-onset dystonia [<a class="bk_pop" href="#dystonia-ov.REF.fahn.1987">Fahn et al 1987</a>]. Therefore, the presence of dystonia in a child must be considered a potential sign of complex and often severe disease, and warrants thorough assessment.</p></div><div id="dystonia-ov.Causes_of_Hereditary_Dystoni"><h2 id="_dystonia-ov_Causes_of_Hereditary_Dystoni_">Causes of Hereditary Dystonia</h2><p>Initially these monogenic disorders were designated DYT followed by a number that represented the chronologic order in which the description of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and/or genetic discovery first appeared in the literature; see <a href="/books/NBK1155/bin/dystonia-ov-Table2.pdf">Table 2</a> (pdf). Although some of the inherited dystonias have a distinct phenotype, considerable phenotypic overlap can occur, making classification based on phenotype alone problematic (for example, DYT-Tor1A and DYT-KMT2B can mimic each other).</p><p>Because of the inconsistencies in the "DYT nomenclature," a naming system that combines the "DYT" designation and the name of associated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> was proposed by <a class="bk_pop" href="#dystonia-ov.REF.marras.2012.1016">Marras et al [2012]</a> and now follows the recommendations for the Nomenclature of Genetic Movement Disorders by the International Parkinson's Disease and Movement Disorder Society Task Force [<a class="bk_pop" href="#dystonia-ov.REF.marras.2016.436">Marras et al 2016</a>] (see <a class="figpopup" href="/books/NBK1155/table/dystonia-ov.T.nomenclature_system_for_in/?report=objectonly" target="object" rid-figpopup="figdystoniaovTnomenclaturesystemforin" rid-ob="figobdystoniaovTnomenclaturesystemforin">Table 3</a>). This naming system eliminates previously listed loci that were erroneous, duplicated, or unconfirmed as well as disorders that were not predominantly dystonic. Distinguishing paroxysmal movement disorders by replacing "DYT" with "PxMD" is recommended by <a class="bk_pop" href="#dystonia-ov.REF.marras.2016.436">Marras et al [2016]</a>. Of note, genes associated with an increased risk for dystonia &#x02013; but not meeting a threshold to be considered a gene in which pathogenic variants are causative &#x02013; are not included.</p><div id="dystonia-ov.T.nomenclature_system_for_in" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Nomenclature System for Inherited (Monogenic) Forms of Isolated Dystonia and Combined Dystonia/Dyskinesia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1155/table/dystonia-ov.T.nomenclature_system_for_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__dystonia-ov.T.nomenclature_system_for_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_1" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Form of Dystonia</th><th id="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Locus Name</th><th id="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">New Designation &#x00026; Phenotypic Subgroup</th><th id="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Additional Distinguishing Features</th><th id="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th></tr></thead><tbody><tr><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_1" rowspan="5" colspan="2" scope="row" style="text-align:left;vertical-align:middle;"><b>Isolated</b></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TOR1A</i></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DYT1</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/dystonia/">DYT-TOR1A</a></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Childhood or adolescent-onset, generalized</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>THAP1</i></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DYT6</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DYT-THAP1</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Adolescent-onset, cranial or generalized</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>ANO3</i></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DYT24</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DYT-ANO3</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Adult-onset, focal or segmental</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>GNAL</i></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DYT25</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DYT-GNAL</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mostly adult-onset, focal or segmental</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>KMT2B</i></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DYT28</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/kmt2b-dystonia/">DYT-KMT2B</a></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early-onset, generalized, mild <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> features</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_1" rowspan="11" scope="row" colspan="1" style="text-align:justify;vertical-align:middle;"><b>Combined</b></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_1" rowspan="6" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dystonia plus parkinsonism</b></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GCH1</i></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DYT5a</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/drd/">DYT-GCH1</a></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dopa-responsive</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD, AR</td></tr><tr><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>TH</i></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DYT5b</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/thdrd/">DYT-TH</a></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dopa-responsive</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>SPR</i></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not assigned</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/spr-def/">DYT-SPR</a></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dopa-responsive, cognitive impairment</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>TAF1</i>&#x000a0;<sup>1</sup></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DYT3</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/xdp/">DYT-TAF1</a></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neurodegeneration</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td></tr><tr><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>PRKRA</i></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DYT16</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DYT-PRKRA</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dystonia w/mild parkinsonism</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>ATP1A3</i></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DYT12</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/rapid-odp/">DYT-ATP1A3</a></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rapid-onset</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Dystonia plus myoclonus</b></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SGCE</i></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DYT11</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/myo-dystonia/">DYT-SGCE</a></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Psychiatric disease</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_1" rowspan="4" colspan="1" scope="row" style="text-align:left;vertical-align:middle;"><b>Paroxysmal</b><br /><b>dystonia</b><br /><b>+ other</b><br /><b>dyskinesia</b></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PNKD</i>&#x000a0;<sup>2</sup></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DYT8</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pnknd/">PxMD-PNKD</a></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Paroxysmal nonkinesigenic dyskinesia</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>PRRT2</i></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DYT10</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/prrt2-parox/">PxMD-PRRT2</a></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Paroxysmal kinesigenic dyskinesia</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>SLC2A1</i></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DYT18</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/glut1/">PxMD-SLC2A1</a></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Paroxysmal exertion-induced dyskinesia</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>ECHS1</i></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not assigned</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/echs1-def/">PxMD-ECHS1</a></td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Paroxysmal exertion induced dyskinesia</td><td headers="hd_h_dystonia-ov.T.nomenclature_system_for_in_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="dystonia-ov.TF.3.1"><p class="no_margin">Pathogenicity of <i>TAF1</i> variants unconfirmed but <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for founder haplotype linked to disease is possible and can be used for diagnostic purposes.</p></div></dd><dt>2. </dt><dd><div id="dystonia-ov.TF.3.2"><p class="no_margin">Previously known as <i>MR-1</i></p></div></dd></dl></div></div></div><div id="dystonia-ov.Isolated_Dystonias"><h3>Isolated Dystonias</h3><p><a href="/books/n/gene/dystonia/"><b>DYT-TOR1A</b></a> (early-onset generalized dystonia) typically first manifests in childhood (mean age 13 years, range 1-28 years) as twisting of an extremity. Symptoms tend to start in lower parts of the body, progressing to involve other limbs and the torso, but usually not the face or neck [<a class="bk_pop" href="#dystonia-ov.REF.bressman.2000.1746">Bressman et al 2000</a>]. Penetrance is reduced; approximately 35% of persons <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>TOR1A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. If manifestations are not evident in a person heterozygous for a <i>TOR1A</i> pathogenic variant by age 28 years, that individual will usually remain symptom-free for life. Expressivity varies with respect to age of onset, site of onset, and progression. Individuals with later onset or onset in the arms tend to be less severely affected. A specific <i>TOR1A</i> pathogenic variant, a three-<a class="def" href="/books/n/gene/glossary/def-item/base-pair/">base pair</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000113.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000113.2</a>:c.907_909delGAG) in the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a>, accounts for about 60% of generalized dystonia in the non-Jewish population and about 90% in the <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> population as a result of a <a class="def" href="/books/n/gene/glossary/def-item/founder-effect/">founder effect</a> [<a class="bk_pop" href="#dystonia-ov.REF.ozelius.1997.40">Ozelius et al 1997</a>].</p><p><b>DYT-THAP1</b> (adolescent-onset segmental/generalized dystonia). Although some phenotypic overlap with DYT-TOR1A is observed, the onset of DYT-THAP1 is later (mean 19 years; range 5-38 years) and cranial involvement is more prominent especially in muscles of the tongue, larynx, and face, with dysphonia being a predominant feature. DYT-THAP1 was first identified in three Mennonite families who are related to a common ancestor [<a class="bk_pop" href="#dystonia-ov.REF.fuchs.2009.286">Fuchs et al 2009</a>]. Currently more than 90 different pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> and truncating <i>THAP1</i> variants have been reported &#x02013; mainly in people from Europe but also from China and Brazil [<a class="bk_pop" href="#dystonia-ov.REF.blanchard.2011.1775">Blanchard et al 2011</a>]. Penetrance is estimated at 50%.</p><p><b>DYT-ANO3</b> (adult-onset focal or segmental dystonia). Pathogenic variants in <i>ANO3</i> were initially reported in individuals with predominantly craniocervical dystonia with a widely variable age of onset [<a class="bk_pop" href="#dystonia-ov.REF.charlesworth.2012.1041">Charlesworth et al 2012</a>]. Pathogenic variants were detected in about 1% of individuals with dystonia and shown to cosegregate with the disease <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in small family pedigrees. Notably, a large number of <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants can be found in variant databases and in healthy individuals, however, the presence of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> variant in <i>ANO3</i> supports pathogenicity of the variant [<a class="bk_pop" href="#dystonia-ov.REF.zech.2017.549">Zech et al 2017</a>].</p><p><b>DYT-GNAL</b> (adult-onset segmental dystonia) is characterized by cervical or cranial dystonia that often begins in the fourth decade (range 7-54 years) [<a class="bk_pop" href="#dystonia-ov.REF.fuchs.2013.88">Fuchs et al 2013</a>]. About 30 different <i>GNAL</i> pathogenic variants, mostly in the <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> state, have been reported in individuals with dystonia and are spread over the entire <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. <i>GNAL</i> pathogenic variants appear to be highly but not fully penetrant [<a class="bk_pop" href="#dystonia-ov.REF.vemula.2013.2510">Vemula et al 2013</a>].</p><p><a href="/books/n/gene/kmt2b-dystonia/"><b>DYT-KMT2B</b></a> (early-onset, generalized dystonia with mild <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> features) is characterized by early-onset, generalized dystonia, which may be clinically indistinguishable from DYT-TOR1A and may be the most common cause of early-onset generalized dystonia, at least outside the Askenazi Jewish population [<a class="bk_pop" href="#dystonia-ov.REF.zech.2016.1377">Zech et al 2016</a>, <a class="bk_pop" href="#dystonia-ov.REF.meyer.2017.223">Meyer et al 2017</a>].</p><p>As <i>KMT2B</i> has only very recently been described in conjunction with dystonia and mild <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> features, it remains to be determined whether DYT-KMT2B falls under the "<a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a>" or "complex" category of inherited dystonias. Given the broad phenotypic overlap with DYT-TOR1A and only mild and inconsistent expression of microcephaly, intellectual disability, developmental delay, seizures, spasticity, eye movement abnormalities, and facial dysmorphism, it has been tentatively grouped in the "isolated dystonias" category.</p></div><div id="dystonia-ov.Combined_Dystonias"><h3>Combined Dystonias</h3><div id="dystonia-ov.Dystonia_Plus_Parkinsonism"><h4>Dystonia Plus Parkinsonism</h4><p><a href="/books/n/gene/drd/"><b>DYT-GCH1</b></a>
<b>(GTP cyclohydrolase 1-deficient dopa-responsive dystonia)</b> is characterized by childhood-onset dystonia and a dramatic and sustained response to low doses of oral administration of levodopa. The average age of onset is approximately six years. This disorder typically presents with gait disturbance caused by foot dystonia, later development of parkinsonism, and diurnal fluctuation of symptoms. Non-motor features including sleep disturbances, mood disorders, and migraine are present in a considerable subset of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#dystonia-ov.REF.tadic.2012.1558">Tadic et al 2012</a>]. In general, gradual progression to generalized dystonia is observed. Intellectual, cerebellar, sensory, and autonomic disturbances generally do not occur. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> with reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> &#x02013; particularly in males. Both inter- and intrafamilial phenotypic variability is reported.</p><p><a href="/books/n/gene/thdrd/"><b>DYT-TH</b></a> is an incompletely dopa-responsive infancy-onset dystonia caused by tyrosine hydroxylase deficiency. Onset is between age 12 months and six years; initial symptoms are typically lower-limb dystonia and/or difficulty in walking. Diurnal fluctuation of symptoms (worsening of the symptoms toward the evening and their alleviation in the morning after sleep) may be present. Other typical clinical features include bradykinesia and hypotonia (both of which can be severe), autonomic disturbances (particularly facial flushing), ptosis, and oculogyric crises.</p><p><a href="/books/n/gene/spr-def/"><b>DYT-SPR</b></a> is a rare cause of partially dopa-responsive childhood-onset dystonia characterized by axial hypotonia, motor and speech delay, weakness, and oculogyric crises; symptoms show diurnal fluctuation and sleep benefit. Other common features include parkinsonian signs, limb hypertonia, hyperreflexia, intellectual disability, psychiatric and/or behavioral abnormalities, autonomic dysfunction, and sleep disturbances.</p><p><a href="/books/n/gene/xdp/"><b>DYT-TAF1</b></a> is endemic on Panay Island in the Philippines [<a class="bk_pop" href="#dystonia-ov.REF.lee.2011.3">Lee et al 2011</a>], where it is known as "lubag" in the local Filipino dialect, meaning "twisted." DYT-TAF1 is characterized by a combination of dystonia and parkinsonism, and is the only known "DYT" with documented neurodegeneration. Penetrance is complete in men. Although almost all women who are obligate heterozygotes are unaffected, 14 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> females with phenotypes of variable severity have been reported. The exact <i>TAF1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> remains a matter of debate since several variants (disease haplotype) segregate with the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. A disease-specific change (DSC) within <i>TAF1</i> [<a class="bk_pop" href="#dystonia-ov.REF.herzfeld.2013.941">Herzfeld et al 2013</a>] or a retrotransposon (SVA) <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> [<a class="bk_pop" href="#dystonia-ov.REF.kawarai.2013.167">Kawarai et al 2013</a>] are under discussion as potential disease-causing mechanisms [<a class="bk_pop" href="#dystonia-ov.REF.domingo.2015.1334">Domingo et al 2015</a>].</p><p><b>DYT-PRKRA</b> is characterized by dystonia with prominent oromandibular involvement, dysphagia, and retrocollis. Parkinsonian features are mild (or even absent) and do not respond to levodopa therapy [<a class="bk_pop" href="#dystonia-ov.REF.camargos.2008.207">Camargos et al 2008</a>]. Recently, a number of reports described single families with the <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_003690.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_003690.4</a>:c.665C&#x0003e;T (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_003681.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_003681.1</a>:p.Pro222Leu) variant in <i>PRKRA</i> and thus confirmed pathogenicity of this change [<a class="bk_pop" href="#dystonia-ov.REF.quadri.2016.765">Quadri et al 2016</a>] in the context of dystonia.</p><p><a href="/books/n/gene/rapid-odp/"><b>DYT-ATP1A3</b></a> is characterized by rapid onset of dystonia with parkinsonism (primarily bradykinesia and postural instability); a rostra-caudal (face&#x0003e;arm&#x0003e;leg) gradient of involvement including bulbar regions; and no response to an adequate trial of L-dopa therapy [<a class="bk_pop" href="#dystonia-ov.REF.brashear.2007.828">Brashear et al 2007</a>]. Anxiety, depression, and seizures have been reported. The age of onset ranges from four to 55 years. Fever, physiologic stress, or alcoholic binges often trigger the onset of symptoms. After their initial appearance, findings commonly stabilize, but with little improvement. Occasionally, subsequent episodes cause abrupt worsening. Penetrance is incomplete. <i>ATP1A3</i> pathogenic variants can also cause alternating hemiplegia of childhood presenting with episodes of weakness and/or dystonia, seizures, and gradual cognitive decline [<a class="bk_pop" href="#dystonia-ov.REF.heinzen.2014.503">Heinzen et al 2014</a>].</p></div><div id="dystonia-ov.Dystonia_with_Myoclonus"><h4>Dystonia with Myoclonus</h4><p><a href="/books/n/gene/myo-dystonia/"><b>DYT-SGCE</b></a> is characterized by a combination of myoclonus and (in most individuals) dystonia [<a class="bk_pop" href="#dystonia-ov.REF.zimprich.2001.66">Zimprich et al 2001</a>]. Many heterozygotes for an <i>SGCE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> develop psychiatric features in addition to or instead of the movement disorder [<a class="bk_pop" href="#dystonia-ov.REF.weissbach.2013.422">Weissbach et al 2013</a>]. Maternal <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> of <i>SGCE</i> explains the observation that the vast majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals inherit their pathogenic variant from their fathers; in contrast, those inheriting the variant from their mothers will likely remain unaffected throughout their lives [<a class="bk_pop" href="#dystonia-ov.REF.m_ller.2002.1303">M&#x000fc;ller et al 2002</a>].</p></div><div id="dystonia-ov.Paroxysmal_Dystonia_with_Oth"><h4>Paroxysmal Dystonia with Other Dyskinesia</h4><p><a href="/books/n/gene/pnknd/"><b>PxMD-PNKD</b></a>
<b>(Paroxysmal nonkinesigenic dyskinesia)</b> attacks are usually a combination of dystonia, chorea, athetosis, and ballismus; last from minutes to hours; and in the most severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may occur several times a week. Attacks can be precipitated by alcohol and caffeine as well as by stress, hunger, fatigue, and tobacco. Two <i>PNKD</i> (formerly <i>MR-1</i>) pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_015488.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_015488.4</a>:c.20C&#x0003e;T (p.Ala7Val) and NM_015488.4:c.26C&#x0003e;T p.Ala9Val) are causative [<a class="bk_pop" href="#dystonia-ov.REF.lee.2004.3161">Lee et al 2004</a>]. Other likely pathogenic variants were found in single families [<a class="bk_pop" href="#dystonia-ov.REF.ghezzi.2009.1058">Ghezzi et al 2009</a>, <a class="bk_pop" href="#dystonia-ov.REF.gardiner.2015.3567">Gardiner et al 2015</a>].</p><p><a href="/books/n/gene/prrt2-parox/"><b>PxMD-PRRT2</b></a>
<b>(paroxysmal kinesigenic dyskinesia)</b> attacks are mostly dystonia, choreoathetosis, and ballism triggered by sudden movement. Attacks usually last several minutes and may occur up to 100 times per day. Onset is usually in childhood or adolescence [<a class="bk_pop" href="#dystonia-ov.REF.bhatia.2011.1157">Bhatia 2011</a>]. Heterozygous <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> and truncating <i>PRRT2</i> variants were identified as the cause of DYT-PRRT2 [<a class="bk_pop" href="#dystonia-ov.REF.chen.2011.1252">Chen et al 2011</a>] as well as the allelic disorders benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> infantile seizures (BFIS) and the syndrome of rolandic epilepsy, paroxysmal exercise-induced dyskinesia, and writer's cramp [<a class="bk_pop" href="#dystonia-ov.REF.schmidt.2012.668">Schmidt et al 2012</a>, <a class="bk_pop" href="#dystonia-ov.REF.heron.2013.133">Heron &#x00026; Dibbens 2013</a>]. In addition, phenotypes associated with pathogenic variants in <i>PRRT2</i> included a high frequency of migraines and hemiplegic migraine [<a class="bk_pop" href="#dystonia-ov.REF.gardiner.2015.3567">Gardiner et al 2015</a>].</p><p><b>PxMD-SLC2A1 (paroxysmal exertion-induced dyskinesia).</b> The attacks are characterized by the combination of chorea, athetosis, and dystonia in exercised body regions. The legs are most frequently affected. A single attack lasts from a few minutes to an hour and occurs after prolonged physical exercise. Of note, <i>SLC2A1</i> pathogenic variants can be associated with variable phenotypes also including paroxysmal kinesigenic dyskinesia, paroxysmal nonkinesigenic dyskinesia, episodic ataxia, and myotonia [<a class="bk_pop" href="#dystonia-ov.REF.gardiner.2015.3567">Gardiner et al 2015</a>]. In addition to the movement disorder, other disease manifestations can include epilepsy, hemolytic anemia, and migraine.</p><p><b><i>ECHS1-</i>related paroxysmal dyskinesia</b> (see <a href="/books/n/gene/echs1-def/">Mitochondrial Short-Chain Enoyl-CoA Hydratase 1 Deficiency</a>). Biallelic <i>ECHS1</i> pathogenic variants are typically associated with severe infantile Leigh-like syndromes. Biallelic <i>ECHS1</i> pathogenic variants have recently been reported in individuals with milder phenotypes characterized by paroxysmal exertion-induced dystonia with prominent axial involvement, particularly opisthotonus. Onset is typically between age two and four years. Interictally, some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children are asymptomatic, others have a mild-to-moderate Leigh-like syndrome with speech problems, dysphagia, pyramidal involvement, and cognitive impairment. Pallidal hyperintensities on brain MRI are very characteristic [<a class="bk_pop" href="#dystonia-ov.REF.olgiati.2016.1041">Olgiati et al 2016</a>, <a class="bk_pop" href="#dystonia-ov.REF.mahajan.2017.185">Mahajan et al 2017</a>].</p></div></div><div id="dystonia-ov.Complex_Dystonias"><h3>Complex Dystonias</h3><p>Although complex dystonias share dystonia as a manifestation, atypical features and additional neurologic signs are often observed. These may include:</p><ul><li class="half_rhythm"><div>Sustained dystonia at rest (whereas <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> or combined dystonia is usually action- or posture-dependent)</div></li><li class="half_rhythm"><div>Prominent tongue and perioral involvement leading to a <i>risus sardonicus</i> (i.e., fixed, exaggerated, or distorted smiling)</div></li><li class="half_rhythm"><div>Pyramidal or cerebellar signs</div></li><li class="half_rhythm"><div>Ataxia</div></li><li class="half_rhythm"><div>Oculomotor abnormalities</div></li><li class="half_rhythm"><div>Cognitive disturbances</div></li><li class="half_rhythm"><div>Hearing loss</div></li><li class="half_rhythm"><div>Intellectual disability / developmental delay</div></li><li class="half_rhythm"><div>Seizures</div></li></ul><p>Although the list of complex dystonias is long and unwieldy, certain rules and patterns help to make an accurate diagnosis and tailor management. Grouping the complex dystonias into those that are hereditary neurodegenerative or metabolic disorders (see <a class="figpopup" href="/books/NBK1155/table/dystonia-ov.T.complex_dystonias_inherite/?report=objectonly" target="object" rid-figpopup="figdystoniaovTcomplexdystoniasinherite" rid-ob="figobdystoniaovTcomplexdystoniasinherite">Table 4</a>) and those that are acquired due to brain lesions, drugs, or psychological causes (see <a class="figpopup" href="/books/NBK1155/table/dystonia-ov.T.nongenetic_causes_of_dysto/?report=objectonly" target="object" rid-figpopup="figdystoniaovTnongeneticcausesofdysto" rid-ob="figobdystoniaovTnongeneticcausesofdysto">Table 5</a>) has proven useful.</p><div id="dystonia-ov.T.complex_dystonias_inherite" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Complex Dystonias: Inherited Neurodegenerative/Metabolic Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1155/table/dystonia-ov.T.complex_dystonias_inherite/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__dystonia-ov.T.complex_dystonias_inherite_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clues to the Diagnosis</th></tr></thead><tbody><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Neurodegenerative diseases</b></td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/drpla/">DRPLA</a> (dentatorubral-pallidolysian atrophy)</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATN1</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Huntington disease like; prominent myoclonus</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/huntington/">Huntington disease</a> (Westphal variant juvenile- or childhood-onset HD)</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HTT</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Family history; caudate atrophy on MRI</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/hd-l2/">Huntington disease-like 2</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>JPH3</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">African ancestry</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rett or Rett-like syndrome</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL, AD</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MECP2, FOXG1, GNB1</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unusual stereotypies; autism</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/jpd/">Parkin type of early-onset Parkinson disease</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PARK2</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Abnormal DaTscan</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/chac/">Chorea-acanthocytosis</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR (&#x00026; possible AD)</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>VPS13A</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Acanthocytes in blood smear</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mcleod/">McLeod neuroacanthocytosis syndrome</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>XK</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Weak expression of Kell antigens; acanthocytes in blood smear</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neuronal intranuclear inclusion disease</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD or <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MRI: high-intensity signal in cortico-medullary junction on DWI images; intranuclear inclusions on skin biopsies</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Disorders leading to brain calcification</b></td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/bgc/">Primary familial brain calcification</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PDGFB</i>, <i>PDGFRB</i>, <i>SLC20A2, XPR1</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MRI/CT: calcifications in basal ganglia, white matter &#x00026; cerebellum</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Disorders of heavy metal metabolism</b></td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/wilson/">Wilson disease</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATP7B</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02193; plasma ceruloplasmin; Kaiser-Fleischer corneal ring; face of the giant panda sign on MRI</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" colspan="3" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/hmdpc/">Hypermanganesemia with dystonia, polycythemia, and cirrhosis</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC30A10</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">T<sub>1</sub>-weighted hyperintensities in basal ganglia &#x00026; cerebellum on MRI</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC39A14</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/nbia-ov/"><b>Neurodegeneration with brain iron accumulation </b></a><b>(NBIA)</b></td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mt-mpan/">Mitochondrial membrane protein-associated neurodegeneration</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>C19orf12</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">T<sub>2</sub>-weighted hypointensities in substantia nigra &#x00026; globus pallidus on MRI; T<sub>2</sub>-weighted hyperintense streaking between hypointense internal globus pallidus &#x00026; external globus pallidus</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/acp/">Aceruloplasminemia</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CP</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MRI: hypointensity of basal ganglia, thalamus, red nucleus, occipital cortex, &#x00026; cerebellar dentate nuclei on T<sub>2</sub>-weighted images</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/wss/">Woodhouse-Sakati syndrome</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DCAF17</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dystonia deafness syndrome; hypogonadism; alopecia</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fahn/">Fatty acid hydroxylase-associated neurodegeneration</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FA2H</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MRI: hypointensity of the globus pallidus, confluent hyperintensities of white matter on T<sub>2</sub>-weighted images, pontocerebellar atrophy, thin corpus callosum</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/neuroferritin/">Neuroferritinopathy</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FTL</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MRI: cystic lesions in the basal ganglia, bilateral pallidal necrosis; hypointensity of caudate, globus pallidus, putamen, substantia nigra, &#x00026; red nuclei on T<sub>2</sub>-weighted images</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pkan/">Pantothenate kinase-associated neurodegeneration</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PANK2</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Eye of the tiger sign on MRI</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/inad/"><i>PLA2G6</i>-associated neurodegeneration</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PLA2G6</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cerebellar hypoplasia &#x00026; T<sub>2</sub>-weighted high signal in the cerebellum on MRI</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/bpan/">Beta-propeller protein-associated neurodegeneration</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>WDR45</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MRI: hypointense globus pallidus &#x00026; substantia nigra on T<sub>2</sub>-weighted images</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Lipid storage disorders</b></td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ncl/">Neuronal ceroid-lipofuscinoses</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR; adult-onset AD or AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATP13A2</i>, <i>CLN3</i>, <i>CLN5</i>, <i>CLN6</i>, <i>CLN8</i>, <i>CTSD</i>, <i>CTSF</i>, <i>DNAJC5</i>, <i>GRN</i>, <i>KCTD7, MFSD8</i>, <i>PPT1</i>, <i>TPP1</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dementia; epilepsy; visual loss in children</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fucosidosis</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FUCA1</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MRI: hypointensity of globus pallidus &#x00026; substantia nigra on T<sub>2</sub>-weighted images; dysostosis multiplex</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/npc/">Niemann-Pick disease type C</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NPC1</i>, <i>NPC2</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Supranuclear gaze palsy, splenomegaly, &#x02191; oxysterol blood levels</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Sphingolipidosis</b></td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mld/">Arylsulfatase A deficiency</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ARSA</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Progressive demyelination</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Lysosomal storage diseases</b></td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/krabbe/">Krabbe disease</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GALC</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Progressive demyelination, enlargement of optic nerve &#x00026; chiasm</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/gm1-ganglio/">GM1-gangliosidosis</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GLB1</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MRI: hyperintensity of caudate nucleus &#x00026; putamen w/signs of diffuse hypomyelination on T<sub>2</sub>-weighted images</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GM2-gangliosidosis, AB variant</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GM2A</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Indistinguishable from GM1-gangliosidosis</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/leukodys-ov/"><b>Leukodystrophies</b></a></td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/creatine/">Creatine deficiency syndromes</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GAMT</i>, <i>GATM, SLC6A8</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MR spectroscopy: no creatine peak</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pmd/">Pelizaeus-Merzbacher disease</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PLP1</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypomyelination on MRI</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Disorders of purine metabolism</b></td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/lns/">Lesch-Nyhan syndrome</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HPRT1</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Self-mutilation; &#x02191; uric acid in plasma &#x00026; urine</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mt-overview/"><b>Mitochondrial disorders</b></a></td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/narp/">Leigh syndrome</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR, mt</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pathogenic variants in the mtDNA; nuclear genes <sup>1</sup></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bilateral basal ganglia lesions on MRI; &#x02191; lactate levels on MR spectroscopy</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/lhon/">Leber hereditary optic neuropathy</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">mt</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pathogenic variants in the mtDNA</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Optic nerve changes on fundoscopy</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/melas/">MELAS</a> (mitochondrial encephalomyopathy, lactic acidosis, and stroke like episodes)</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">mt</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pathogenic variants in the mtDNA</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Deep white matter changes &#x00026; stroke-like lesions on MRI</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/merrf/">MERRF</a> (myoclonus epilepsy associated with ragged red fibers)</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">mt</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pathogenic variants in the mtDNA</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Progressive myoclonus, epilepsy, &#x00026; ataxia; muscle biopsy showing ragged red fibers; &#x02191; lactate in serum &#x00026; CSF</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/alpers/"><i>POLG</i>-related disorders</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR, AD</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>POLG</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Progressive external ophthalmoplegia, ataxia</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ddon/">Deafness-dystonia-optic neuronopathy syndrome</a> (Mohr-Tranebjaerg syndrome)</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TIMM8A</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dystonia (particularly oromandibular) &#x00026; deafness</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Other dystonia-deafness syndromes</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SERAC1, SUCLA2</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dystonia &#x00026; deafness</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DDP</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dystonia &#x00026; deafness</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Organic acidurias</b></td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">D-2-hydroxyglutaric aciduria</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>D2HGDH</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Newborn screening</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Glutaric aciduria type 1</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GCDH</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Newborn screening</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mma/">Methylmalonic acidemia</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MCEE</i>, <i>MMAA</i>, <i>MMAB</i>, <i>MMADHC, MMUT</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Newborn screening</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Aminoacidurias</b></td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/homocystinuria/">Homocystinuria caused by cystathionine &#x003b2;-synthase deficiency</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CBS</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Homocysteine levels &#x02191; in blood</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pku/">Phenylketonuria</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PAH</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Newborn screening</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hartnup disorder</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC6A19</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Levels of neutral amino acids &#x02191; in urine</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Disorders of biotin metabolism</b></td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/biotin/">Biotinidase deficiency</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>BTD</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Newborn screening</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Disorders of thiamine metabolism</b></td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/bgd-biotin/">Biotin-thiamine-responsive basal ganglia disease</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC19A3</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Recurrent subacute encephalopathy; symmetric &#x00026; bilateral edematous lesions in caudate nucleus, putamen, &#x00026; cortex on MRI</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Disorders of galactose metabolism</b></td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/galactosemia/">Classic galactosemia and clinical variant galactosemia</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GALT</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Newborn screening</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Encephalopathy with uncertain pathogenesis</b></td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ags/">Aicardi-Gouti&#x000e8;res syndrome</a></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD, AR</td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ADAR1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>TREX1</i></td><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early-onset encephalopathy; chilblain lesions</td></tr><tr><td headers="hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_1 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_2 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_3 hd_h_dystonia-ov.T.complex_dystonias_inherite_1_1_1_4" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Disorders w/ataxia as a predominant feature, particularly AD SCA (e.g., <a href="/books/n/gene/sca3/">SCA3</a>) &#x00026; AR early-onset ataxias (e.g., <a href="/books/n/gene/ataxia-telangiectas/">ataxia-telangiectasia</a>)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; DWI = diffusion-weighted imaging; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; mt = mitochondrial; SCA = spinocerebellar ataxia; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="dystonia-ov.TF.4.1"><p class="no_margin">Genes associated with mitochondrial DNA-associated Leigh syndrome and NARP: <i>BCS1L, C20ORF7, C8ORF38, COX10, COX15, FOXRED1, MTFMT, NDUFA2, NDUFA9, NDUFA10, NDUFA12, NDUFAF2, NDUFAF6, NDUFS1, NDUFS3, NDUFS4, NDUFS7, NDUFS8, SDHA, SURF1</i></p></div></dd></dl></div></div></div><p><b>Neurodegenerative diseases</b></p><ul><li class="half_rhythm"><div><a href="/books/n/gene/huntington/">Huntington disease</a>. The cardinal movement disorder in Huntington disease is chorea, at least in adults. However, about 10% of individuals with Huntington disease have childhood onset (referred to as Westphal variant), which typically manifests as (1) focal or segmental dystonia (rather than chorea) that gradually becomes generalized and (2) parkinsonism [<a class="bk_pop" href="#dystonia-ov.REF.bruyn.1986">Bruyn &#x00026; Went 1986</a>]. Craniocervical dystonia including risus sardonicus is common and is often accompanied by speech and swallowing problems. Childhood-onset Huntington disease is more common when the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is paternally inherited. It is accompanied by a larger number of CAG repeats [<a class="bk_pop" href="#dystonia-ov.REF.went.1984.1100">Went et al 1984</a>].</div></li><li class="half_rhythm"><div><a href="/books/n/gene/chac/">Chorea-acanthocytosis</a> is characterized by severe orolingual dystonia leading to chewing problems and sometimes mutilation of the lips, tongue, or cheeks (so called "eating dystonia") [<a class="bk_pop" href="#dystonia-ov.REF.schneider.2007.517">Schneider et al 2007</a>]. Other characteristic movement abnormalities include generalized chorea, motor and vocal tics, intermittent head drop, and sometimes parkinsonism.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/mcleod/">McLeod neuroacanthocytosis syndrome</a> is defined as absent expression of the Kx erythrocyte antigen and weakened expression of Kell blood group antigens causing red blood cell acanthocytosis and compensated hemolysis. It is a multisystem disorder manifesting with sensorimotor axonopathy, muscle weakness, neuropsychiatric and cognitive disturbances, and movement disorders, particularly generalized chorea and orolingual dystonia.</div></li><li class="half_rhythm"><div>Rett syndrome. Asymmetric crural or generalized dystonia is common in Rett syndrome [<a class="bk_pop" href="#dystonia-ov.REF.temudo.2008.1384">Temudo et al 2008</a>]. It occurs almost exclusively in girls because it is embryonic lethal in males. Following a near-normal early development <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> girls develop autism, dementia, epilepsy, spastic paraparesis or tetraparesis, and characteristic stereotypies (hand clapping, knitting movements, or body rocking). After an initial rapid progression, symptoms usually stabilize, so that these individuals often survive into adulthood.</div></li></ul><p><b>Disorders leading to brain calcification</b></p><ul><li class="half_rhythm"><div><a href="/books/n/gene/bgc/">Primary familial brain calcification</a> can present with dystonia in addition to cognitive and psychiatric symptoms. Vascular and brain parenchymal calcification, consisting primarily of calcium phosphate, is found in the basal ganglia and other brain areas including the cerebellum, thalamus, and brain stem.</div></li></ul><p><b>Disorders of heavy metal metabolism</b></p><ul><li class="half_rhythm"><div><a href="/books/n/gene/wilson/">Wilson disease</a>, a disorder of copper metabolism, typically includes craniocervical dystonia that can be severe, early speech and swallowing problems, and other bulbar signs.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/hmdpc/">Hypermanganesemia with dystonia, polycythemia, and cirrhosis</a> resembles Wilson disease but is caused by disturbances of manganese metabolism. It is characterized by early-onset generalized dystonia and adult-onset parkinsonism. Serum manganese levels are elevated and brain MRI examination shows hyperintensities in the basal ganglia as well as in the subthalamic and dentate nuclei typical for hypermanganesemia.</div></li></ul><p><b>Neurodegeneration with brain iron accumulation (NBIA)</b> is a group of disorders characterized by progressive iron storage in the brain and abnormal iron accumulation in the basal ganglia, which is evident as hypointense lesions predominantly (but not exclusively) in the globus pallidus and substantia nigra pars reticulata on T<sub>2</sub>-weighted images. On T<sub>1</sub>-weighted images, these regions are isointense. See <a href="/books/n/gene/nbia-ov/">NBIA Overview</a>.</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/mt-mpan/">Mitochondrial membrane protein-associated neurodegeneration</a> is characterized by dystonia that frequently involves limbs and occasionally becomes generalized [<a class="bk_pop" href="#dystonia-ov.REF.hogarth.2013.268">Hogarth et al 2013</a>]. Associated features are parkinsonism with varying combinations of bradykinesia, rigidity, tremor and postural instability, cognitive decline progressing to dementia, prominent neuropsychiatric abnormalities, and motor neuronopathy. Brain MRI shows a distinctive pattern of brain iron accumulation with T<sub>2</sub>-weighted/gradient echo hypointensities in the substantia nigra and globus pallidus, often with unique T<sub>2</sub>-weighted hyperintense streaking between the hypointense internal and external globus pallidus.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/fahn/">Fatty acid hydroxylase-associated neurodegeneration</a> presents in childhood with spastic tetraparesis, ataxia, and often generalized dystonia, followed by episodic neurologic decline. Brain MRI typically demonstrates T<sub>2</sub>-weighted hypointensity in the globus pallidus, confluent T<sub>2</sub>-weighted white matter hyperintensities, and profound pontocerebellar atrophy [<a class="bk_pop" href="#dystonia-ov.REF.kruer.2010.611">Kruer et al 2010</a>].</div></li><li class="half_rhythm"><div><a href="/books/n/gene/neuroferritin/">Neuroferritinopathy</a> typically presents with progressive adult-onset chorea or dystonia and subtle cognitive deficits. The movement disorder involves additional limbs within five to ten years and becomes more generalized within 20 years. When present, asymmetry remains throughout the course of the disease. The majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals develop a characteristic orofacial action-specific dystonia induced by speech leading to dysarthria and dysphonia. Frontalis overactivity, orolingual dyskinesia, and dysphagia are also common. Brain MRI often shows cystic lesions in the basal ganglia and bilateral pallidal necrosis, in addition to iron accumulation in the caudate, globus pallidus, putamen, substantia nigra, and red nuclei.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/pkan/">Pantothenate kinase associated neurodegeneration</a> (PKAN) accounts for approximately 50% of NBIA. In classic PKAN, onset is early, usually before age six years and progression is rapid. Affected children often present with dystonic gait, dysarthria, and limb rigidity. Corticospinal tract involvement causes spasticity. A central region of hyperintensity in the globus pallidus with surrounding hypointensity on T<sub>2</sub>-weighted images ("eye-of-the-tiger sign") is pathognomonic for PKAN and is highly correlated with the presence of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>PANK2</i> pathogenic variants.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/inad/"><i>PLA2G6</i>-associated neurodegeneration</a> (PLAN) comprises a continuum of three phenotypes with overlapping clinical and radiologic features: classic infantile neuroaxonal dystrophy (INAD), atypical neuroaxonal dystrophy (atypical NAD), and <i>PLA2G6</i>-related dystonia-parkinsonism. Progressive dystonia associated with dysarthria and behavioral abnormalities including hyperactivity and impulsivity is common in NAD (onset age ~4 years), but not in INAD. <i>PLA2G6</i>-related dystonia-parkinsonism is characterized by juvenile parkinsonism associated with pyramidal signs, dementia, psychiatric features, and cerebral and cerebellar atrophy without brain iron accumulation on MRI [<a class="bk_pop" href="#dystonia-ov.REF.paisanruiz.2009.19">Paisan-Ruiz et al 2009</a>, <a class="bk_pop" href="#dystonia-ov.REF.hayflick.2013.1708">Hayflick et al 2013</a>].</div></li><li class="half_rhythm"><div><a href="/books/n/gene/bpan/">Beta-propeller protein-associated neurodegeneration</a> is characterized by developmental delay with further regression in early adulthood and by progressive dystonia, parkinsonism, and dementia. Seizures, spasticity, and disordered sleep are also common. Although the parkinsonism is L-dopa responsive, nearly all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have early motor fluctuations and develop disabling dyskinesia. Brain MRI shows iron deposition in the substantia nigra and globus pallidus, with a characteristic "halo" of T<sub>1</sub>-weighted hyperintense signal in the substantia nigra [<a class="bk_pop" href="#dystonia-ov.REF.hayflick.2013.1708">Hayflick et al 2013</a>].</div></li></ul><p><b>Lipid storage disorders</b></p><ul><li class="half_rhythm"><div><a href="/books/n/gene/npc/">Niemann-Pick type C</a>, juvenile variant, is a sphingomyelin storage disease with onset in preschool or early school years, characterized by splenomegaly, behavioral abnormalities, ataxia, and supranuclear gaze palsy. Progressive generalized dystonia typically involving the orofacial muscles is also common.</div></li></ul><p><b>Mitochondrial disorders</b></p><ul><li class="half_rhythm"><div><a href="/books/n/gene/narp/">Leigh syndrome</a>, a progressive neurodegenerative disorder, is characterized by developmental regression and signs of brain stem dysfunction including respiratory abnormalities and nystagmus. Other common manifestations include optic atrophy, ophthalmoparesis, failure to thrive, hypotonia, weakness, spasticity, ataxia, seizures, bulbar problems, and dystonia. The characteristic neuropathologic features are symmetric necrotic lesions in the basal ganglia, cerebellum, thalamus, brain stem, and optic nerves [<a class="bk_pop" href="#dystonia-ov.REF.lera.1994.642">Lera et al 1994</a>].</div></li><li class="half_rhythm"><div><a href="/books/n/gene/lhon/">Leber hereditary optic neuropathy</a> typically presents in young adults as painless subacute bilateral visual failure. Dystonia can be part of the clinical presentation [<a class="bk_pop" href="#dystonia-ov.REF.wang.2009.337">Wang et al 2009</a>].</div></li><li class="half_rhythm"><div><a href="/books/n/gene/ddon/">Deafness-dystonia-optic neuronopathy syndrome</a> (Mohr-Tranebjaerg syndrome) is characterized by profound sensorineural hearing loss in early childhood that precedes the onset of dystonia which ranges from the first to the sixth decades (peaking in the second and third decades). Dystonia tends to be focal, segmental, or multifocal in distribution at onset, with a predilection for the upper body, variably involving the head, neck, and upper limbs [<a class="bk_pop" href="#dystonia-ov.REF.ha.2012.1034">Ha et al 2012</a>]. In most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males dystonia generalizes regardless of the onset age.</div></li></ul><p><b>Organic acidurias</b></p><ul><li class="half_rhythm"><div>Glutaric aciduria type 1 (OMIM <a href="https://omim.org/entry/231670" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">231670</a>) caused by glutaryl-CoA-dehydrogenase deficiency is associated with gliosis and neuronal loss in the basal ganglia resulting in dystonia [<a class="bk_pop" href="#dystonia-ov.REF.harting.2009.1764">Harting et al 2009</a>]. The classic clinical scenario is acute encephalopathy triggered by infection or immunization with rapid onset of chorea and hypotonia, followed in months and years by the gradual development of severe generalized dystonia. Dystonia at rest with action-induced exacerbation, which profoundly interferes with any voluntary movement, is often incapacitating. Dysarthria and dysphagia are also common, whereas cognitive functions can be preserved. Early diagnosis and special diet can prevent encephalopathic crises and thus improve the prognosis considerably.</div></li></ul><p><b>Disorders of thiamine metabolism</b></p><ul><li class="half_rhythm"><div><a href="/books/n/gene/bgd-biotin/">Biotin-thiamine-responsive basal ganglia disease</a> typically presents in childhood with subacute episodes of encephalopathy triggered by febrile illness and characterized by confusion, dysarthria, dysphagia, and external ophthalmoplegia. The disease is progressive and leads to persistent severe dystonia, quadriparesis, or coma and death if untreated. Symptoms resolve within a few days following administration of high doses of biotin and thiamine. The precise mechanism by which biotin and thiamine improve symptoms is unclear. Brain MRI typically shows symmetric and bilateral lesions in the caudate nucleus and putamen, infra- and supratentorial brain cortex, and brain stem [<a class="bk_pop" href="#dystonia-ov.REF.tabarki.2013.261">Tabarki et al 2013</a>].</div></li></ul><div id="dystonia-ov.Other_Genetic_Causes_of_Comp"><h4>Other Genetic Causes of Complex Dystonia</h4><p>Of note, both <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> spinocerebellar ataxias (SCAs) and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> ataxias can be associated with dystonia (see <a href="/books/n/gene/ataxias/">Hereditary Ataxia</a>). The most common of the autosomal dominant SCAs (i.e., <a href="/books/n/gene/sca1/">SCA1</a>, <a href="/books/n/gene/sca2/">SCA2</a>, <a href="/books/n/gene/sca3/">SCA3</a>, and <a href="/books/n/gene/sca6/">SCA6</a>) together account for more than half of all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> families. Signs of cerebellar dysfunction are often accompanied by other clinical features [<a class="bk_pop" href="#dystonia-ov.REF.schmitzh_bsch.2008.982">Schmitz-H&#x000fc;bsch et al 2008</a>]. Dystonia is sometimes present and can be the most prominent sign.</p><p>Dystonia is also part of the clinical presentation in some <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> ataxias including <a href="/books/n/gene/friedreich/">Friedreich ataxia</a>, <a href="/books/n/gene/aved/">ataxia with vitamin E deficiency</a>, <a href="/books/n/gene/ataxia-telangiectas/">ataxia-telangiectasia</a> (A-T), and <a href="/books/n/gene/aoa/">ataxia with oculomotor apraxia type 1</a> (AOA1) and <a href="/books/n/gene/aoa2/">type 2</a> (AOA2). Dystonia in these disorders typically involves the craniocervical region and the arms [<a class="bk_pop" href="#dystonia-ov.REF.fogel.2007.245">Fogel &#x00026; Perlman 2007</a>]. In A-T, AOA1, and AOA2 difficulty with head-eye coordination related to saccadic failure is common.</p></div></div></div><div id="dystonia-ov.NonGenetic_Causes_of_Dystoni"><h2 id="_dystonia-ov_NonGenetic_Causes_of_Dystoni_">Non-Genetic Causes of Dystonia</h2><div id="dystonia-ov.T.nongenetic_causes_of_dysto" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Non-Genetic Causes of Dystonia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1155/table/dystonia-ov.T.nongenetic_causes_of_dysto/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__dystonia-ov.T.nongenetic_causes_of_dysto_lrgtbl__"><table><thead><tr><th id="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cause</th><th id="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Etiology</th><th id="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Examples</th></tr></thead><tbody><tr><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_1" rowspan="9" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Acquired brain lesions</b></td><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypoxic insults</td><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cerebral palsy<br />Bronchopulmonary dysplasia</td></tr><tr><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Infections</td><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Creutzfeldt-Jakob disease<br />Mycoplasma pneumonia<br />Japanese B encephalitis<br />Tuberculosis</td></tr><tr><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Parainfectious disorders</td><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reye syndrome<br />Subacute sclerosing panencephalitis</td></tr><tr><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Autoimmune disorders</td><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multiple sclerosis<br />Antiphospholipid-antibody syndrome</td></tr><tr><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Metabolic disorders</td><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Kernicterus<br />Hypoparathyroidism<br />Central pontine myelinolysis</td></tr><tr><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Vascular insults</td><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Stroke<br />Arteriovenous malformation</td></tr><tr><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Traumatic brain injury</td><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Space-occupying lesions</td><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Intoxications</td><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Carbon monoxide<br />Manganese</td></tr><tr><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Drug-induced dystonia</b></td><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neuroleptics</td><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Anticonvulsants</td><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Psychogenic dystonia</b></td><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_dystonia-ov.T.nongenetic_causes_of_dysto_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div></div><p><b>Complex dystonias caused by brain lesions.</b> Typically, acquired brain lesions that cause dystonia affect the ipsilateral putamen, thalamus, and/or globus pallidus, resulting in contralateral hemidystonia [<a class="bk_pop" href="#dystonia-ov.REF.marsden.1985.463">Marsden et al 1985</a>, <a class="bk_pop" href="#dystonia-ov.REF.m_nchau.2000.494">M&#x000fc;nchau et al 2000</a>] (i.e., as a rule hemidystonia results from circumscribed contralateral brain lesions). For unknown reasons dystonia resulting from such brain lesions develops months after the initial insult. Aberrant reorganization has been postulated but remains unproven. Also, although the distribution of weakness and sensory symptoms can usually be predicted on the basis of lesion location, the development of dystonia after basal ganglia lesions are identified is not predictable as most individuals with such lesions do not develop dystonia.</p><p>The most common and clinically relevant cause of dystonia due to (gross or subtle) brain lesions is cerebral palsy (CP). Dystonia (along with chorea) is the presenting and prevailing finding in persons with dyskinetic CP, but can also be observed in other forms of CP (e.g., spastic hemiparesis, spastic paraparesis, or spastic tetraparesis) [<a class="bk_pop" href="#dystonia-ov.REF.johnston.2004">Johnston 2004</a>]. In children with dyskinetic CP, generalized dystonia often evolves between ages two and six years; however, onset of dystonia can be delayed for several years [<a class="bk_pop" href="#dystonia-ov.REF.saint_hilaire.1991.216">Saint Hilaire et al 1991</a>]. Involvement of oromandibular, lingual, and pharyngeal muscles is common, leading to characteristic risus sardonicus, speech problems, and dysphagia. In addition, limb and axial dystonia can be common. Physical disability can be very severe; cognitive ability is often not impaired.</p><p><b>Drug-induced dystonia</b> can occur in adults and children. The two main forms are acute dystonic reactions and tardive dystonia.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Acute dystonic reactions</b> result within hours or days of taking a dopamine-blocking medication (mostly neuroleptics). They usually manifest as oromandibular or cervical dystonia and subside when the causative medication is discontinued.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Tardive dystonia</b> results from use of all classes of neuroleptics and usually can manifest at any time (ranging from several days to many years after beginning use of the medication) [<a class="bk_pop" href="#dystonia-ov.REF.kiriakakis.1998.2053">Kiriakakis et al 1998</a>]. At its onset, tardive dystonia is usually focal but often progresses over months or years. The craniocervical region is typically involved.</div><div class="half_rhythm">The manifestations of tardive dystonia are often indistinguishable from those of primary focal dystonia; however, retrocollis and axial involvement are characteristic. Like DYT1 dystonia, the site of onset tends to ascend from the lower limbs cranially as the mean age of onset increases [<a class="bk_pop" href="#dystonia-ov.REF.kiriakakis.1998.2053">Kiriakakis et al 1998</a>]. Other abnormal movements can include orofaciolingual dyskinesias, abnormal breathing rhythm due to involvement of the diaphragm, and truncal hypokinesia. Tardive dystonia tends to persist and is difficult to treat. Chances of remission are greater in persons who have taken neuroleptics for shorter periods or in whom neuroleptics are discontinued.</div></li></ul><p><b>Psychogenic dystonia.</b> Diagnostic criteria for psychogenic dystonia have been proposed [<a class="bk_pop" href="#dystonia-ov.REF.williams.1995.231">Williams et al 1995</a>]. "Clinically definite" psychogenic dystonia is diagnosed in individuals: (1) in whom persistent symptoms are relieved by psychotherapy, suggestion, or placebo; or (2) who fail to manifest dystonia when they feel that they are not being observed. Other criteria for "clinically definite" psychogenic dystonia, such as "dystonia is incongruent with classic dystonia, or inconsistencies are noted in the examination," are more equivocal.</p><p>Positive signs of psychogenic dystonia include: sudden onset and remissions (e.g., following a psychological or physical trauma); a history of somatization; co-contraction of agonists and antagonists without abnormal postures; distractibility; suggestibility; fluctuating severity within short periods; discrepancies between objective signs and disability; and psychopathologic abnormalities. None of these signs, however, is diagnostic.</p><p>In individuals with a confirmed diagnosis of psychogenic dystonia, psychotherapy should be undertaken promptly since early initiation of treatment is associated with a better prognosis.</p><p>Criteria mentioned above and knowledge about the natural history of psychogenic dystonia are predominantly based on studies in adults; however, reports in children with psychogenic movement disorders including dystonia suggest that similar "rules" also apply to children [<a class="bk_pop" href="#dystonia-ov.REF.schwingenschuh.2008.1882">Schwingenschuh et al 2008</a>].</p></div><div id="dystonia-ov.Evaluation_Strategy"><h2 id="_dystonia-ov_Evaluation_Strategy_">Evaluation Strategy</h2><p>Once the diagnosis of dystonia has been established in an individual, the following approach can be used to determine the specific cause of dystonia to aid in discussions of prognosis and <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a>. Establishing the specific cause of dystonia for a given individual usually involves a medical history, physical examination, neurologic examination, and neuroimaging, as well as detailed family history and use of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. It is especially important to look for treatable causes of dystonia such as dopa-responsive dystonia (<a href="/books/n/gene/drd/">DYT-GCH1</a>, <a href="/books/n/gene/thdrd/">DYT-TH</a>, and <a href="/books/n/gene/spr-def/">DYT-SPR</a>), <a href="/books/n/gene/wilson/">Wilson disease</a>, and other rare metabolic disorders and toxic or drug-related associations.</p><div id="dystonia-ov.History"><h3>History</h3><p>Prenatal and birth history should be documented, particularly any history of birth asphyxia or drug history, and especially the use of antidopaminergic agents or L-dopa.</p></div><div id="dystonia-ov.Clinical_Findings"><h3>Clinical Findings</h3><p>Important features are age of onset, site of onset, presence or absence of other neurologic abnormalities, and presence of non-neurologic abnormalities (e.g., developmental delay, <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features). Presence or absence of associated findings may help distinguish among <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> dystonia, combined dystonia, and complex dystonia.</p><p>Delineation of the dystonia <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and the clinical course, the first step when evaluating persons with dystonia, can be diagnostic. For example,</p><ul><li class="half_rhythm"><div>Sudden onset of dystonia over a range of ages is compatible with <a href="/books/n/gene/rapid-odp/">rapid-onset dystonia-parkinsonism</a> (DYT-ATP1A3) (formerly DYT12).</div></li><li class="half_rhythm"><div>Many dystonias can be triggered or exacerbated by nonspecific factors, such as stress, fatigue, action, or certain postures.</div></li><li class="half_rhythm"><div>A "therapeutic" response to alcohol is characteristic of <a href="/books/n/gene/myo-dystonia/">myoclonus-dystonia</a> (DYT-SGCE), and improvement with L-dopa supports a diagnosis of dopa-responsive dystonia (<a href="/books/n/gene/drd/">DYT-GCH1</a>, <a href="/books/n/gene/thdrd/">DYT-TH</a>, and <a href="/books/n/gene/spr-def/">DYT-SPR</a>).</div></li></ul></div><div id="dystonia-ov.Family_History"><h3>Family History</h3><p>A three-generation family history with attention to other relatives with neurologic signs and symptoms should be obtained. Documentation of relevant findings in relatives can be accomplished either through direct examination of those individuals or review of their medical records including the results of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, neuroimaging studies, and the results of autopsy examinations.</p></div><div id="dystonia-ov.Testing"><h3>Testing</h3><p>Non-DNA-based clinical tests for the following are available (also see <a class="figpopup" href="/books/NBK1155/table/dystonia-ov.T.complex_dystonias_inherite/?report=objectonly" target="object" rid-figpopup="figdystoniaovTcomplexdystoniasinherite" rid-ob="figobdystoniaovTcomplexdystoniasinherite">Table 4</a>):</p><ul><li class="half_rhythm"><div>Dopa-responsive dystonia (DYT-GCH1, DYT-TH, and <a href="/books/n/gene/spr-def/">DYT-SPR</a>). Trial of L-dopa, abnormal phenylalanine loading test, measurement of the concentration of total biopterin (BP) (most of which exists as BH4) and neopterin (NP) (the by-product of the GTPCH1 reaction) in CSF is useful for the diagnosis of GTPCH1-deficient DRD. In <a href="/books/n/gene/drd/">GTPCH1-deficient dopa-responsive dystonia</a>, the concentrations of BP and NP in CSF are low, whereas in <a href="/books/n/gene/thdrd/">TH-deficient dopa-responsive dystonia</a>, the concentrations of both BP and NP in CSF are normal.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/bgc/">Primary familial brain calcification</a> (bilateral striatopallidodentate calcinosis). Brain calcification is best detected using CT scanning [<a class="bk_pop" href="#dystonia-ov.REF.manyam.1992.379">Manyam et al 1992</a>].</div></li><li class="half_rhythm"><div><a href="/books/n/gene/nbia-ov/">Neurodegeneration with brain iron accumulation</a>. Iron deposition is detected on brain MRI.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/chac/">Chorea-acanthocytosis</a>. Peripheral blood films show acanthocytosis; serum creatine kinase concentration may be elevated.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/mcleod/">McLeod neuroacanthocytosis syndrome</a>. Expression of Kell antigens is weak.</div></li><li class="half_rhythm"><div>Diagnostic workup in persons with dystonia and cerebellar signs &#x02013; even when cerebellar signs are subtle &#x02013; should include testing for <a href="/books/n/gene/ataxias/">spinocerebellar ataxia</a> if family history suggests <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance.</div></li></ul><div id="dystonia-ov.Molecular_Genetic_Testing"><h4>Molecular Genetic Testing</h4><p>Molecular genetic testing approaches can include a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> sequencing</b>, and <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>.</p><p><b>Option 1</b></p><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> focused on dystonia that includes the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) of interest. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each gene vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>Option 2</b></p><p><b>Comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when clinically available) includes <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>. For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><p><b>Option 3</b></p><p><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> In contrast to <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing, single-gene testing relies on the clinician developing a hypothesis about which specific gene to test based on the individual's clinical findings, ethnicity, and/or the order in which pathogenic variants in a given gene most commonly occur.</p><ul><li class="half_rhythm"><div>In individuals of Ashkenaki Jewish ancestry, targeted testing for the specific <i>TOR1A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, a three-<a class="def" href="/books/n/gene/glossary/def-item/base-pair/">base pair</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000113.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000113.2</a>:c.907_909delGAG) in the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> can be considered first.</div></li><li class="half_rhythm"><div>In individuals without clinical findings or ethnic background to suggest a specific <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, single-gene testing is rarely useful and typically NOT recommended given the genetic heterogeneity of dystonia; a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> or comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing are generally used in lieu of single-gene testing.</div></li></ul></div></div></div><div id="dystonia-ov.Genetic_Counseling"><h2 id="_dystonia-ov_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="dystonia-ov.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><b>Genetic counseling.</b> While hereditary, <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a>, and combined dystonias are usually inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner, complex dystonias are often inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> or mitochondrial manner. In general, <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> forms are rare but should be considered. Genetic counseling and risk assessment depend on determination of the specific cause of an inherited dystonia in an individual.</p><p>Importantly, most dominant forms of dystonia are characterized by reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, which can be lower than 50%. For two hereditary dystonias, mechanisms affecting penetrance have been identified:</p><ul><li class="half_rhythm"><div>DYT-SGCE only manifests when <i>SGCE</i> pathogenic variants are paternally inherited due to maternal <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> of this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> [<a class="bk_pop" href="#dystonia-ov.REF.m_ller.2002.1303">M&#x000fc;ller et al 2002</a>].</div></li><li class="half_rhythm"><div>Penetrance of the GAG <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in <i>TOR1A</i>, is reduced from about 35% to 3% in individuals who also have a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000113.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000113.2</a>:646G&#x0003e;C ( p.Asp216His) variant in <i>TOR1A</i> on the other <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> [<a class="bk_pop" href="#dystonia-ov.REF.risch.2007.1188">Risch et al 2007</a>].</div></li></ul></div><div id="dystonia-ov.Autosomal_Dominant_Inheritan"><h3>Autosomal Dominant Inheritance &#x02013; Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Individuals with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> dystonia inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from one parent or have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may include <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> or clinical evaluation if molecular genetic testing is not available.</div></li><li class="half_rhythm"><div>The family history may appear to be negative because of failure to recognize the disorder in family members, reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, early death of the parent before the onset of symptoms, or late onset of the disease in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Therefore, an apparently negative family history cannot be confirmed unless appropriate <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> and/or clinical evaluation have been performed.</div></li><li class="half_rhythm"><div>Note: Due to reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, there may be asymptomatic family members or several generations of individuals with the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> who remain symptom free.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to sibs depends on the genetic status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if one of the proband's parents has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the pathogenic variant is 50%.</div></li><li class="half_rhythm"><div>Because many of the inherited dystonias demonstrate incomplete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, not all individuals who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will develop dystonia.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Each child of an individual with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> dystonia has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Because many of the inherited dystonias demonstrate incomplete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, not all individuals who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will develop dystonia.</div></li></ul><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the dystonia-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="dystonia-ov.Autosomal_Recessive_Inherita"><h3>Autosomal Recessive Inheritance</h3><div id="dystonia-ov.Risk_to_Family_Members"><h4>Risk to Family Members</h4><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one dystonia-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes are asymptomatic.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a 25% chance of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes are asymptomatic.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> All offspring are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a dystonia-related <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a dystonia-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="dystonia-ov.Carrier_Heterozygote_Detecti"><h4>Carrier (Heterozygote) Detection</h4><p>Carrier testing for at-risk relatives requires prior identification of the dystonia-related pathogenic variants in the family.</p></div></div><div id="dystonia-ov.Mitochondrial_Inheritance__R"><h3>Mitochondrial Inheritance &#x02013; Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div><b>Single mtDNA deletions</b></div><ul><li class="half_rhythm"><div>Mitochondrial DNA (mtDNA) deletions generally occur <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> and thus affect only one family member.</div></li><li class="half_rhythm"><div>When single mtDNA deletions are transmitted, inheritance is from the mother.</div></li><li class="half_rhythm"><div>The predisposition to form multiple mtDNA deletions can be inherited as an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> or an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> trait.</div></li></ul></li><li class="half_rhythm"><div><b>Mitochondrial DNA single-nucleotide variants and duplications</b></div><ul><li class="half_rhythm"><div>Mitochondrial DNA single-nucleotide variants and duplications may be transmitted through the maternal line.</div></li><li class="half_rhythm"><div>The father of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is not at risk of having the mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>The mother of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> (usually) has the mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and may or may not have symptoms.</div></li></ul></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs depends on the genetic status of the mother: if the mother has the mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, all sibs are at risk of inheriting it.</div></li><li class="half_rhythm"><div>When a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a single mtDNA <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, the current best estimate of the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is 1/24 [<a class="bk_pop" href="#dystonia-ov.REF.chinnery.2004.592">Chinnery et al 2004</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Offspring of males with a mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will not inherit the variant.</div></li><li class="half_rhythm"><div>All offspring of females with a mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are at risk of inheriting the pathogenic variant.</div></li><li class="half_rhythm"><div>A female harboring a <a class="def" href="/books/n/gene/glossary/def-item/heteroplasmic/">heteroplasmic</a> mtDNA <a class="def" href="/books/n/gene/glossary/def-item/single-nucleotide-variant/">single-nucleotide variant</a> may transmit a variable amount of mutated mtDNA to her offspring, resulting in considerable clinical variability among sibs within the same nuclear family [<a class="bk_pop" href="#dystonia-ov.REF.poulton.2000.460">Poulton &#x00026; Turnbull 2000</a>].</div></li></ul><p><b>Other family members.</b> The risk to other family members depends on the genetic status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s mother: if she has a mtDNA <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, her sibs and mother are also at risk.</p></div><div id="dystonia-ov.XLinked_Inheritance"><h3>X-Linked Inheritance</h3><div id="dystonia-ov.Risk_to_Family_Members_1"><h4>Risk to Family Members</h4><p><b>Parents of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will not have the disorder nor will he be <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> for the dystonia-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; therefore, he does not require further evaluation/testing.</div></li><li class="half_rhythm"><div>In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother of an affected male is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-heterozygote/">obligate heterozygote</a> (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>). Note: If a woman has more than one affected child and no other affected relatives and if the dystonia-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in her leukocyte DNA, she most likely has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li><li class="half_rhythm"><div>If a male is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member (i.e., a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case), the mother may be a <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>) or the affected male may have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, in which case the mother is not a carrier.</div></li></ul><p><b>Sibs of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs depends on the genetic status of the proband's mother:</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has the dystonia-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%. Males who inherit the variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; females who inherit the variant will be heterozygotes (carriers) and will not typically be affected.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the dystonia-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of the mother, the risk to sibs is slightly greater than that of the general population (though still &#x0003c;1%) because of the possibility of maternal <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Affected males will transmit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to all of their daughters and none of their sons.</p><p><b>Other family members.</b> The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s maternal aunts may be at risk of being carriers and the aunt's offspring, depending on their gender, may be at risk of being carriers or of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p><p><b>Other family members.</b> The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s maternal aunts may be at risk of being heterozygotes (carriers) for the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and the aunts' offspring, depending on their gender, may be at risk of being heterozygotes (carriers) for the pathogenic variant or of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p></div><div id="dystonia-ov.Heterozygote_Carrier_Detecti"><h4>Heterozygote (Carrier) Detection</h4><p>Molecular genetic testing of at-risk female relatives to determine their genetic status is most informative if the dystonia-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</p></div></div><div id="dystonia-ov.Related_Genetic_Counseling_I"><h3>Related Genetic Counseling Issues</h3><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="dystonia-ov.Prenatal_Testing_and_Preimpl"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Mutation of nuclear DNA.</b> Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for dystonia are possible.</p><p><b>Mutation of mitochondrial DNA (mtDNA).</b> Prenatal <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> and interpretation for mtDNA disorders is difficult because of mtDNA <a class="def" href="/books/n/gene/glossary/def-item/heteroplasmy/">heteroplasmy</a>. The percentage level of mutated mtDNA in a chorionic villus sampling (CVS) biopsy may not reflect the percentage level of mutated mtDNA in other fetal tissues, and the percentage level may change during development and throughout life [<a class="bk_pop" href="#dystonia-ov.REF.hellebrekers.2012.341">Hellebrekers et al 2012</a>].</p></div></div><div id="dystonia-ov.Resources"><h2 id="_dystonia-ov_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Dystonia Coalition</b></div><div><i>The Dystonia Coalition is a collaboration of medical researchers and patient advocacy groups that is working to advance the pace of clinical and translational research in the dystonias to find better treatments.</i></div><div><a href="http://www.rarediseasesnetwork.org/cms/dystonia/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.rarediseasesnetwork.org/cms/dystonia</a></div></li><li class="half_rhythm"><div><b>Dystonia Europe</b></div><div>Square de Meeus 37</div><div>4th Floor</div><div> Brussels Hoofdstedelijk Gewest 1000</div><div>Belgium</div><div><b>Phone:</b> 46 739 98 49 61</div><div><b>Email:</b> sec@dystonia-europe.org</div><div><a href="https://dystonia-europe.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.dystonia-europe.org</a></div></li><li class="half_rhythm"><div><b>Dystonia Medical Research Foundation</b></div><div>One East Wacker Drive</div><div>Suite 1730</div><div>Chicago IL 60601-1905</div><div><b>Phone:</b> 800-377-3978 (toll-free); 312-755-0198</div><div><b>Fax:</b> 312-803-0138</div><div><b>Email:</b> dystonia@dystonia-foundation.org</div><div><a href="http://www.dystonia-foundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.dystonia-foundation.org</a></div></li><li class="half_rhythm"><div><b>Dystonia Society</b></div><div>89 Albert Embankment</div><div>3rd Floor</div><div>London SE1 7TP</div><div>United Kingdom</div><div><b>Phone:</b> 0845 458 6211; 0845 458 6322 (Helpline)</div><div><b>Fax:</b> 0845 458 6311</div><div><b>Email:</b> support@dystonia.org.uk</div><div><a href="http://www.dystonia.org.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.dystonia.org.uk</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/dystonia.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Dystonia</a></div></li><li class="half_rhythm"><div><b>German Dystonia Network and Registry</b></div><div>Germany</div><div><a href="http://www.research4rare.de/en/research_networks/dystract-3/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.research4rare.de</a></div></li><li class="half_rhythm"><div><b>Global Dystonia Registry</b></div><div><a href="http://www.globaldystoniaregistry.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.globaldystoniaregistry.org</a></div></li></ul></div><div id="dystonia-ov.References"><h2 id="_dystonia-ov_References_">References</h2><div id="dystonia-ov.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.bhatia.2011.1157">Bhatia KP. Paroxysmal dyskinesias. <span><span class="ref-journal">Mov Disord. </span>2011;<span class="ref-vol">26</span>:1157–65.</span> [<a href="/pubmed/21626559" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21626559</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.blanchard.2011.1775">Blanchard A, Roubertie A, Simonetta-Moreau M, Ea V, Coquart C, Frederic MY, Gallouedec G, Adenis JP, Benatru I, Borg M, Burbaud P, Calvas P, Cif L, Damier P, Destee A, Faivre L, Guyant-Marechal L, Janik P, Janoura S, Kreisler A, Lusakowska A, Odent S, Potulska-Chromik A, Rudzi&#x00144;ska M, Thobois S, Vuillaume I, Tranchant C, Tuffery-Giraud S, Coubes P, Sablonni&#x000e8;re B, Claustres M, Collod-B&#x000e9;roud G. Singular DYT6 phenotypes in association with new THAP1 frameshift mutations. <span><span class="ref-journal">Mov Disord. </span>2011;<span class="ref-vol">26</span>:1775–7.</span> [<a href="/pubmed/21520283" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21520283</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.brashear.2007.828">Brashear A, Dobyns WB, de Carvalho Aguiar P, Borg M, Frijns CJ, Gollamudi S, Green A, Guimaraes J, Haake BC, Klein C, Linazasoro G, M&#x000fc;nchau A, Raymond D, Riley D, Saunders-Pullman R, Tijssen MA, Webb D, Zaremba J, Bressman SB, Ozelius LJ. The phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 gene. <span><span class="ref-journal">Brain. </span>2007;<span class="ref-vol">130</span>:828–35.</span> [<a href="/pubmed/17282997" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17282997</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.bressman.2000.1746">Bressman SB, Sabatti C, Raymond D, de Leon D, Klein C, Kramer PL, Brin MF, Fahn S, Breakefield X, Ozelius LJ, Risch NJ. The DYT1 phenotype and guidelines for diagnostic testing. <span><span class="ref-journal">Neurology. </span>2000;<span class="ref-vol">54</span>:1746–52.</span> [<a href="/pubmed/10802779" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10802779</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.bruyn.1986">Bruyn GW, Went CN. Huntington's chorea. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Handbook of Clinical Neurology. Amsterdam, Netherlands: North Holland Publishing Company; 1986:267-314.</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.camargos.2008.207">Camargos S, Scholz S, Sim&#x000f3;n-S&#x000e1;nchez J, Pais&#x000e1;n-Ruiz C, Lewis P, Hernandez D, Ding J, Gibbs JR, Cookson MR, Bras J, Guerreiro R, Oliveira CR, Lees A, Hardy J, Cardoso F, Singleton AB. DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA. <span><span class="ref-journal">Lancet Neurol. </span>2008;<span class="ref-vol">7</span>:207–15.</span> [<a href="/pubmed/18243799" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18243799</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.charlesworth.2012.1041">Charlesworth G, Plagnol V, Holmstr&#x000f6;m KM, Bras J, Sheerin UM, Preza E, Rubio-Agusti I, Ryten M, Schneider SA, Stamelou M, Trabzuni D, Abramov AY, Bhatia KP, Wood NW. Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">91</span>:1041–50.</span> [<a href="/pmc/articles/PMC3516598/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3516598</span></a>] [<a href="/pubmed/23200863" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23200863</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.chen.2011.1252">Chen WJ, Lin Y, Xiong ZQ, Wei W, Ni W, Tan GH, Guo SL, He J, Chen YF, Zhang QJ, Li HF, Lin Y, Murong SX, Xu J, Wang N, Wu ZY. Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. <span><span class="ref-journal">Nat Genet. </span>2011;<span class="ref-vol">43</span>:1252–5.</span> [<a href="/pubmed/22101681" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22101681</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.chinnery.2004.592">Chinnery PF, DiMauro S, Shanske S, Schon EA, Zeviani M, Mariotti C, Carrara F, Lombes A, Laforet P, Ogier H, Jaksch M, Lochm&#x000fc;ller H, Horvath R, Deschauer M, Thorburn DR, Bindoff LA, Poulton J, Taylor RW, Matthews JN, Turnbull DM. Risk of developing a mitochondrial DNA deletion disorder. <span><span class="ref-journal">Lancet. </span>2004;<span class="ref-vol">364</span>:592–6.</span> [<a href="/pubmed/15313359" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15313359</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.domingo.2015.1334">Domingo A, Westenberger A, Lee LV, Br&#x000e6;nne I, Liu T, Vater I, Rosales R, Jamora RD, Pasco PM, Cutiongco-Dela Paz EM, Freimann K, Schmidt TG, Dressler D, Kaiser FJ, Bertram L, Erdmann J, Lohmann K, Klein C. New insights into the genetics of X-linked dystonia-parkinsonism (XDP, DYT3). <span><span class="ref-journal">Eur J Hum Genet. </span>2015;<span class="ref-vol">23</span>:1334–40.</span> [<a href="/pmc/articles/PMC4592086/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4592086</span></a>] [<a href="/pubmed/25604858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25604858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.fahn.1987">Fahn S, Marsden CD, Calne DB. Classification and investigation of dystonia. In: Marsden CD, Fahn S, eds. <em>Movement Disorders.</em> 2 ed. London, UK: Butterworth; 1987:332-58.</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.fogel.2007.245">Fogel BL, Perlman S. Clinical features and molecular genetics of autosomal recessive cerebellar ataxias. <span><span class="ref-journal">Lancet Neurol. </span>2007;<span class="ref-vol">6</span>:245–57.</span> [<a href="/pubmed/17303531" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17303531</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.fuchs.2009.286">Fuchs T, Gavarini S, Saunders-Pullman R, Raymond D, Ehrlich ME, Bressman SB, Ozelius LJ. Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia. <span><span class="ref-journal">Nat Genet. </span>2009;<span class="ref-vol">41</span>:286–8.</span> [<a href="/pubmed/19182804" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19182804</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.fuchs.2013.88">Fuchs T, Saunders-Pullman R, Masuho I, Luciano MS, Raymond D, Factor S, Lang AE, Liang TW, Trosch RM, White S, Ainehsazan E, Herv&#x000e9; D, Sharma N, Ehrlich ME, Martemyanov KA, Bressman SB, Ozelius LJ. Mutations in GNAL cause primary torsion dystonia. <span><span class="ref-journal">Nat Genet. </span>2013;<span class="ref-vol">45</span>:88–92.</span> [<a href="/pmc/articles/PMC3530620/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3530620</span></a>] [<a href="/pubmed/23222958" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23222958</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.gardiner.2015.3567">Gardiner AR, Jaffer F, Dale RC, Labrum R, Erro R, Meyer E, Xiromerisiou G, Stamelou M, Walker M, Kullmann D, Warner T, Jarman P, Hanna M, Kurian MA, Bhatia KP, Houlden H. The clinical and genetic heterogeneity of paroxysmal dyskinesias. <span><span class="ref-journal">Brain. </span>2015;<span class="ref-vol">138</span>:3567–80.</span> [<a href="/pmc/articles/PMC4655345/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4655345</span></a>] [<a href="/pubmed/26598494" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26598494</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.ghezzi.2009.1058">Ghezzi D, Viscomi C, Ferlini A, Gualandi F, Mereghetti P, DeGrandis D, Zeviani M. Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence. <span><span class="ref-journal">Hum Mol Genet. </span>2009;<span class="ref-vol">18</span>:1058–64.</span> [<a href="/pubmed/19124534" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19124534</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.ha.2012.1034">Ha AD, Parratt KL, Rendtorff ND, Lodahl M, Ng K, Rowe DB, Sue CM, Hayes MW, Tranebjaerg L, Fung VS. The phenotypic spectrum of dystonia in Mohr-Tranebjaerg syndrome. <span><span class="ref-journal">Mov Disord. </span>2012;<span class="ref-vol">27</span>:1034–40.</span> [<a href="/pubmed/22736418" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22736418</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.harting.2009.1764">Harting I, Neumaier-Probst E, Seitz A, Maier EM, Assmann B, Baric I, Troncoso M, M&#x000fc;hlhausen C, Zschocke J, Boy NP, Hoffmann GF, Garbade SF, K&#x000f6;lker S. Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I. <span><span class="ref-journal">Brain. </span>2009;<span class="ref-vol">132</span>:1764–82.</span> [<a href="/pubmed/19433437" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19433437</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.hayflick.2013.1708">Hayflick SJ, Kruer MC, Gregory A, Haack TB, Kurian MA, Houlden HH, Anderson J, Boddaert N, Sanford L, Harik SI, Dandu VH, Nardocci N, Zorzi G, Dunaway T, Tarnopolsky M, Skinner S, Holden KR, Frucht S, Hanspal E, Schrander-Stumpel C, Mignot C, H&#x000e9;ron D, Saunders DE, Kaminska M, Lin JP, Lascelles K, Cuno SM, Meyer E, Garavaglia B, Bhatia K, de Silva R, Crisp S, Lunt P, Carey M, Hardy J, Meitinger T, Prokisch H, Hogarth P. Beta-propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation. <span><span class="ref-journal">Brain. </span>2013;<span class="ref-vol">136</span>:1708–17.</span> [<a href="/pmc/articles/PMC3673459/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3673459</span></a>] [<a href="/pubmed/23687123" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23687123</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.heinzen.2014.503">Heinzen EL, Arzimanoglou A, Brashear A, Clapcote SJ, Gurrieri F, Goldstein DB, J&#x000f3;hannesson SH, Mikati MA, Neville B, Nicole S, Ozelius LJ, Poulsen H, Schyns T, Sweadner KJ, van den Maagdenberg A, Vilsen B, et al.  Distinct neurological disorders with ATP1A3 mutations. <span><span class="ref-journal">Lancet Neurol. </span>2014;<span class="ref-vol">13</span>:503–14.</span> [<a href="/pmc/articles/PMC4238309/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4238309</span></a>] [<a href="/pubmed/24739246" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24739246</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.hellebrekers.2012.341">Hellebrekers DM, Wolfe R, Hendrickx AT, de Coo IF, de Die CE, Geraedts JP, Chinnery PF, Smeets HJ. PGD and heteroplasmic mitochondrial DNA point mutations: a systematic review estimating the chance of healthy offspring. <span><span class="ref-journal">Hum Reprod Update. </span>2012;<span class="ref-vol">18</span>:341–9.</span> [<a href="/pubmed/22456975" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22456975</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.heron.2013.133">Heron SE, Dibbens LM. Role of PRRT2 in common paroxysmal neurological disorders: a gene with remarkable pleiotropy. <span><span class="ref-journal">J Med Genet. </span>2013;<span class="ref-vol">50</span>:133–9.</span> [<a href="/pubmed/23343561" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23343561</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.herzfeld.2013.941">Herzfeld T, Nolte D, Grznarova M, Hofmann A, Schultze JL, Muller U. X-linked dystonia parkinsonism syndrome (XDP, lubag): disease-specific sequence change DSC3 in TAF1/DYT3 affects genes in vesicular transport and dopamine metabolism. <span><span class="ref-journal">Hum Mol Genet. </span>2013;<span class="ref-vol">22</span>:941–51.</span> [<a href="/pubmed/23184149" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23184149</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.hogarth.2013.268">Hogarth P, Gregory A, Kruer MC, Sanford L, Wagoner W, Natowicz MR, Egel RT, Subramony SH, Goldman JG, Berry-Kravis E, Foulds NC, Hammans SR, Desguerre I, Rodriguez D, Wilson C, Diedrich A, Green S, Tran H, Reese L, Woltjer RL, Hayflick SJ. New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN. <span><span class="ref-journal">Neurology. </span>2013;<span class="ref-vol">80</span>:268–75.</span> [<a href="/pmc/articles/PMC3589182/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3589182</span></a>] [<a href="/pubmed/23269600" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23269600</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.johnston.2004">Johnston MV. Encephalopathies. In: Behrman RE, Kleigman RM, Jenson HB, eds. <em>Nelson Textbook of Pedriatrics</em>. 17 ed. Philadelphia, PA: WB Saunders. 2004:2023-9.</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.kawarai.2013.167">Kawarai T, Pasco PM, Teleg RA, Kamada M, Sakai W, Shimozono K, Mizuguchi M, Tabuena D, Orlacchio A, Izumi Y, Goto S, Lee LV, Kaji R. Application of long-range polymerase chain reaction in the diagnosis of X-linked dystonia-parkinsonism. <span><span class="ref-journal">Neurogenetics. </span>2013;<span class="ref-vol">14</span>:167–9.</span> [<a href="/pubmed/23435702" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23435702</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.kiriakakis.1998.2053">Kiriakakis V, Bhatia KP, Quinn NP, Marsden CD. The natural history of tardive dystonia. A long-term follow-up study of 107 cases. <span><span class="ref-journal">Brain. </span>1998;<span class="ref-vol">121</span>:2053–66.</span> [<a href="/pubmed/9827766" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9827766</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.kruer.2010.611">Kruer MC, Pais&#x000e1;n-Ruiz C, Boddaert N, Yoon MY, Hama H, Gregory A, Malandrini A, Woltjer RL, Munnich A, Gobin S, Polster BJ, Palmeri S, Edvardson S, Hardy J, Houlden H, Hayflick SJ. Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). <span><span class="ref-journal">Ann Neurol. </span>2010;<span class="ref-vol">68</span>:611–8.</span> [<a href="/pmc/articles/PMC6059612/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6059612</span></a>] [<a href="/pubmed/20853438" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20853438</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.lee.2004.3161">Lee HY, Xu Y, Huang Y, Ahn AH, Auburger GW, Pandolfo M, Kwiecinski H, Grimes DA, Lang AE, Nielsen JE, Averyanov Y, Servidei S, Friedman A, Van Bogaert P, Abramowicz MJ, Bruno MK, Sorensen BF, Tang L, Fu YH, Pt&#x000e1;cek LJ. The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. <span><span class="ref-journal">Hum Mol Genet. </span>2004;<span class="ref-vol">13</span>:3161–70.</span> [<a href="/pubmed/15496428" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15496428</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.lee.2011.3">Lee LV, Rivera C, Teleg RA, Dantes MB, Pasco PM, Jamora RD, Arancillo J, Villareal-Jordan RF, Rosales RL, Demaisip C, Maranon E, Peralta O, Borres R, Tolentino C, Monding MJ, Sarcia S. The unique phenomenology of sex-linked dystonia parkinsonism (XDP, DYT3, "Lubag"). <span><span class="ref-journal">Int J Neurosci. </span>2011;<span class="ref-vol">121</span> Suppl 1:3–11.</span> [<a href="/pubmed/21047175" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21047175</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.lera.1994.642">Lera G, Bhatia K, Marsden CD. Dystonia as the major manifestation of Leigh's syndrome. <span><span class="ref-journal">Mov Disord. </span>1994;<span class="ref-vol">9</span>:642–9.</span> [<a href="/pubmed/7845405" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7845405</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.mahajan.2017.185">Mahajan A, Constantinou J, Sidiropoulos C. ECHS1 deficiency-associated paroxysmal exercise-induced dyskinesias: case presentation and initial benefit of intervention. <span><span class="ref-journal">J Neurol. </span>2017;<span class="ref-vol">264</span>:185–7.</span> [<a href="/pubmed/28039521" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28039521</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.manyam.1992.379">Manyam BV, Bhatt MH, Moore WD, Devleschoward AB, Anderson DR, Calne DB. Bilateral striopallidodentate calcinosis: cerebrospinal fluid, imaging, and electrophysiological studies. <span><span class="ref-journal">Ann Neurol. </span>1992;<span class="ref-vol">31</span>:379–84.</span> [<a href="/pubmed/1586138" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1586138</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.marras.2016.436">Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Lohmann K, Kostic V, Klein C. Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force. <span><span class="ref-journal">Mov Disord. </span>2016;<span class="ref-vol">31</span>:436–57.</span> [<a href="/pubmed/27079681" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27079681</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.marras.2012.1016">Marras C, Lohmann K, Lang A, Klein C. Fixing the broken system of genetic locus symbols: Parkinson disease and dystonia as examples. <span><span class="ref-journal">Neurology. </span>2012;<span class="ref-vol">78</span>:1016–24.</span> [<a href="/pmc/articles/PMC3310311/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3310311</span></a>] [<a href="/pubmed/22454269" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22454269</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.marsden.1985.463">Marsden CD, Obeso JA, Zarranz JJ, Lang AE. The anatomical basis of symptomatic hemidystonia. <span><span class="ref-journal">Brain. </span>1985;<span class="ref-vol">108</span>:463–83.</span> [<a href="/pubmed/4005532" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4005532</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.meyer.2017.223">Meyer E, Carss KJ, Rankin J, Nichols JM, Grozeva D, Joseph AP, Mencacci NE, Papandreou A, Ng J, Barral S, Ngoh A, Ben-Pazi H, Willemsen MA, Arkadir D, Barnicoat A, Bergman H, Bhate S, Boys A, Darin N, Foulds N, Gutowski N, Hills A, Houlden H, Hurst JA, Israel Z, Kaminska M, Limousin P, Lumsden D, McKee S, Misra S, Mohammed SS, Nakou V, Nicolai J, Nilsson M, Pall H, Peall KJ, Peters GB, Prabhakar P, Reuter MS, Rump P, Segel R, Sinnema M, Smith M, Turnpenny P, White SM, Wieczorek D, Wiethoff S, Wilson BT, Winter G, Wragg C, Pope S, Heales SJ, Morrogh D, Pittman A, Carr LJ, Perez-Due&#x000f1;as B, Lin JP, Reis A, Gahl WA, Toro C, Bhatia KP, Wood NW, Kamsteeg EJ, Chong WK, Gissen P, Topf M, Dale RC, Chubb JR, Raymond FL, Kurian MA, et al.  Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia. <span><span class="ref-journal">Nat Genet. </span>2017;<span class="ref-vol">49</span>:223–37.</span> [<a href="/pubmed/27992417" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27992417</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.m_ller.2002.1303">M&#x000fc;ller B, Hedrich K, Kock N, Dragasevic N, Svetel M, Garrels J, Landt O, Nitschke M, Pramstaller PP, Reik W, Schwinger E, Sperner J, Ozelius L, Kostic V, Klein C. Evidence that paternal expression of the epsilon-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">71</span>:1303–11.</span> [<a href="/pmc/articles/PMC378568/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC378568</span></a>] [<a href="/pubmed/12444570" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12444570</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.m_nchau.2000.494">M&#x000fc;nchau A, Mathen D, Cox T, Quinn NP, Marsden CD, Bhatia KP. Unilateral lesions of the globus pallidus: report of four patients presenting with focal or segmental dystonia. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2000;<span class="ref-vol">69</span>:494–8.</span> [<a href="/pmc/articles/PMC1737132/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1737132</span></a>] [<a href="/pubmed/10990510" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10990510</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.olgiati.2016.1041">Olgiati S, Skorvanek M, Quadri M, Minneboo M, Graafland J, Breedveld GJ, Bonte R, Ozgur Z, van den Hout MC, Schoonderwoerd K, Verheijen FW, van IJcken WF, Chien HF, Barbosa ER, Chang HC, Lai SC, Yeh TH, Lu CS, Wu-Chou YH, Kievit AJ, Han V, Gdovinova Z, Jech R, Hofstra RM, Ruijter GJ, Mandemakers W, Bonifati V. Paroxysmal exercise-induced dystonia within the phenotypic spectrum of ECHS1 deficiency. <span><span class="ref-journal">Mov Disord. </span>2016;<span class="ref-vol">31</span>:1041–8.</span> [<a href="/pubmed/27090768" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27090768</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.ozelius.1997.40">Ozelius LJ, Hewett JW, Page CE, Bressman SB, Kramer PL, Shalish C, de Leon D, Brin MF, Raymond D, Corey DP, Fahn S, Risch NJ, Buckler AJ, Gusella JF, Breakefield XO. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. <span><span class="ref-journal">Nat Genet. </span>1997;<span class="ref-vol">17</span>:40–8.</span> [<a href="/pubmed/9288096" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9288096</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.paisanruiz.2009.19">Paisan-Ruiz C, Bhatia KP, Li A, Hernandez D, Davis M, Wood NW, Hardy J, Houlden H, Singleton A, Schneider SA. Characterization of PLA2G6 as a locus for dystonia-parkinsonism. <span><span class="ref-journal">Ann Neurol. </span>2009;<span class="ref-vol">65</span>:19–23.</span> [<a href="/pubmed/18570303" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18570303</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.poulton.2000.460">Poulton J, Turnbull DM. 74th ENMC international workshop: mitochondrial diseases 19-20 november 1999, Naarden, the netherlands. <span><span class="ref-journal">Neuromuscul Disord. </span>2000;<span class="ref-vol">10</span>:460–2.</span> [<a href="/pubmed/10899455" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10899455</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.quadri.2016.765">Quadri M, Olgiati S, Sensi M, Gualandi F, Groppo E, Rispoli V, Graafland J, Breedveld GJ, Fabbrini G, Berardelli A, Bonifati V. PRKRA mutation causing early-onset generalized dystonia-parkinsonism (DYT16) in an Italian family. <span><span class="ref-journal">Mov Disord. </span>2016;<span class="ref-vol">31</span>:765–7.</span> [<a href="/pubmed/26990861" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26990861</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.risch.2007.1188">Risch NJ, Bressman SB, Senthil G, Ozelius LJ. Intragenic cis and trans modification of genetic susceptibility in DYT1 torsion dystonia. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">80</span>:1188–93.</span> [<a href="/pmc/articles/PMC1867106/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1867106</span></a>] [<a href="/pubmed/17503336" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17503336</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.saint_hilaire.1991.216">Saint Hilaire MH, Burke RE, Bressman SB, Brin MF, Fahn S. Delayed-onset dystonia due to perinatal or early childhood asphyxia. <span><span class="ref-journal">Neurology. </span>1991;<span class="ref-vol">41</span>:216–22.</span> [<a href="/pubmed/1992364" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1992364</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.schmidt.2012.668">Schmidt A, Kumar KR, Redyk K, Gr&#x000fc;newald A, Leben M, M&#x000fc;nchau A, Sue CM, Hagenah J, Hartmann H, Lohmann K, Christen HJ, Klein C. Two faces of the same coin: benign familial infantile seizures and paroxysmal kinesigenic dyskinesia caused by PRRT2 mutations. <span><span class="ref-journal">Arch Neurol. </span>2012;<span class="ref-vol">69</span>:668–70.</span> [<a href="/pubmed/22782515" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22782515</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.schmitzh_bsch.2008.982">Schmitz-H&#x000fc;bsch T, Coudert M, Bauer P, Giunti P, Globas C, Baliko L, Filla A, Mariotti C, Rakowicz M, Charles P, Ribai P, Szymanski S, Infante J, van de Warrenburg BP, D&#x000fc;rr A, Timmann D, Boesch S, Fancellu R, Rola R, Depondt C, Sch&#x000f6;ls L, Zdienicka E, Kang JS, D&#x000f6;hlinger S, Kremer B, Stephenson DA, Melegh B, Pandolfo M, di Donato S, du Montcel ST, Klockgether T. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. <span><span class="ref-journal">Neurology. </span>2008;<span class="ref-vol">71</span>:982–9.</span> [<a href="/pubmed/18685131" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18685131</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.schneider.2007.517">Schneider SA, Walker RH, Bhatia KP. The Huntington's disease-like syndromes: what to consider in patients with a negative Huntington's disease gene test. <span><span class="ref-journal">Nature clinical practice Neurology. </span>2007;<span class="ref-vol">3</span>:517–25.</span> [<a href="/pubmed/17805246" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17805246</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.schwingenschuh.2008.1882">Schwingenschuh P, Pont-Sunyer C, Surtees R, Edwards MJ, Bhatia KP. Psychogenic movement disorders in children: a report of 15 cases and a review of the literature. <span><span class="ref-journal">Mov Disord. </span>2008;<span class="ref-vol">23</span>:1882–8.</span> [<a href="/pubmed/18759366" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18759366</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.tabarki.2013.261">Tabarki B, Al-Shafi S, Al-Shahwan S, Azmat Z, Al-Hashem A, Al-Adwani N, Biary N, Al-Zawahmah M, Khan S, Zuccoli G. Biotin-responsive basal ganglia disease revisited: clinical, radiologic, and genetic findings. <span><span class="ref-journal">Neurology. </span>2013;<span class="ref-vol">80</span>:261–7.</span> [<a href="/pubmed/23269594" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23269594</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.tadic.2012.1558">Tadic V, Kasten M, Br&#x000fc;ggemann N, Stiller S, Hagenah J, Klein C. Dopa-responsive dystonia revisited: diagnostic delay, residual signs, and nonmotor signs. <span><span class="ref-journal">Arch Neurol. </span>2012;<span class="ref-vol">69</span>:1558–62.</span> [<a href="/pubmed/22986512" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22986512</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.temudo.2008.1384">Temudo T, Ramos E, Dias K, Barbot C, Vieira JP, Moreira A, Calado E, Carrilho I, Oliveira G, Levy A, Fonseca M, Cabral A, Cabral P, Monteiro JP, Borges L, Gomes R, Santos M, Sequeiros J, Maciel P. Movement disorders in Rett syndrome: an analysis of 60 patients with detected MECP2 mutation and correlation with mutation type. <span><span class="ref-journal">Mov Disord. </span>2008;<span class="ref-vol">23</span>:1384–90.</span> [<a href="/pubmed/18512755" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18512755</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.vemula.2013.2510">Vemula SR, Puschmann A, Xiao J, Zhao Y, Rudzi&#x00144;ska M, Frei KP, Truong DD, Wszolek ZK, LeDoux MS. Role of Galpha(olf) in familial and sporadic adult-onset primary dystonia. <span><span class="ref-journal">Hum Mol Genet. </span>2013;<span class="ref-vol">22</span>:2510–9.</span> [<a href="/pmc/articles/PMC3658169/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3658169</span></a>] [<a href="/pubmed/23449625" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23449625</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.wang.2009.337">Wang K, Takahashi Y, Gao ZL, Wang GX, Chen XW, Goto J, Lou JN, Tsuji S. Mitochondrial ND3 as the novel causative gene for Leber hereditary optic neuropathy and dystonia. <span><span class="ref-journal">Neurogenetics. </span>2009;<span class="ref-vol">10</span>:337–45.</span> [<a href="/pubmed/19458970" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19458970</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.weissbach.2013.422">Weissbach A, Kasten M, Gr&#x000fc;newald A, Br&#x000fc;ggemann N, Trillenberg P, Klein C, Hagenah J. Prominent psychiatric comorbidity in the dominantly inherited movement disorder myoclonus-dystonia. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2013;<span class="ref-vol">19</span>:422–5.</span> [<a href="/pubmed/23332219" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23332219</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.went.1984.1100">Went LN, Vegter-van der Vlis M, Bruyn GW. Parental transmission in Huntington's disease. <span><span class="ref-journal">Lancet. </span>1984;<span class="ref-vol">1</span>:1100–2.</span> [<a href="/pubmed/6144830" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6144830</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.williams.1995.231">Williams DT, Ford B, Fahn S. Phenomenology and psychopathology related to psychogenic movement disorders. <span><span class="ref-journal">Adv Neurol. </span>1995;<span class="ref-vol">65</span>:231–57.</span> [<a href="/pubmed/7872143" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7872143</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.zech.2017.549">Zech M, Boesch S, Jochim A, Weber S, Meindl T, Schormair B, Wieland T, Lunetta C, Sansone V, Messner M, Mueller J, Ceballos-Baumann A, Strom TM, Colombo R, Poewe W, Haslinger B, Winkelmann J. Clinical exome sequencing in early-onset generalized dystonia and large-scale resequencing follow-up. <span><span class="ref-journal">Mov Disord. </span>2017;<span class="ref-vol">32</span>:549–59.</span> [<a href="/pubmed/27666935" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27666935</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.zech.2016.1377">Zech M, Boesch S, Maier EM, Borggraefe I, Vill K, Laccone F, Pilshofer V, Ceballos-Baumann A, Alhaddad B, Berutti R, Poewe W, Haack TB, Haslinger B, Strom TM, Winkelmann J. Haploinsufficiency of KMT2B, encoding the lysine-specific histone methyltransferase 2B, results in early-onset generalized dystonia. <span><span class="ref-journal">Am J Hum Genet. </span>2016;<span class="ref-vol">99</span>:1377–87.</span> [<a href="/pmc/articles/PMC5142117/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5142117</span></a>] [<a href="/pubmed/27839873" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27839873</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="dystonia-ov.REF.zimprich.2001.66">Zimprich A, Grabowski M, Asmus F, Naumann M, Berg D, Bertram M, Scheidtmann K, Kern P, Winkelmann J, M&#x000fc;ller-Myhsok B, Riedel L, Bauer M, M&#x000fc;ller T, Castro M, Meitinger T, Strom TM, Gasser T. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">29</span>:66–9.</span> [<a href="/pubmed/11528394" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11528394</span></a>]</div></li></ul></div></div><div id="dystonia-ov.Chapter_Notes"><h2 id="_dystonia-ov_Chapter_Notes_">Chapter Notes</h2><div id="dystonia-ov.Author_History"><h3>Author History</h3><p>Christine Klein, MD (2014-present)<br />Katja Lohmann, PhD (2017-present)<br />Connie Marras, MD, PhD (2014-present)<br />Alexander M&#x000fc;nchau, MD (2014-present)<br />Andrea H Nemeth, MRCP, DPhil; Churchill Hospital and Institute of Molecular Medicine (2003-2014)</p></div><div id="dystonia-ov.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>22 June 2017 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>1 May 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>23 January 2006 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>27 May 2005 (cd) Revision: information on neuroferritinopathy</div></li><li class="half_rhythm"><div>21 December 2004 (cd) Revision: information on Mcleod neuroacanthocytosis syndrome</div></li><li class="half_rhythm"><div>3 June 2004 (cd) Revision: change in test availability</div></li><li class="half_rhythm"><div>5 February 2004 (cd) Revision: change in test availability</div></li><li class="half_rhythm"><div>28 October 2003 (me) Review posted live</div></li><li class="half_rhythm"><div>8 April 2003 (an) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1155</span><span class="label">PMID: <a href="/pubmed/20301334" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301334</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/hered-drta/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/hfpoik-tmp/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1155&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1155/?report=reader">PubReader</a></li><li><a href="/books/NBK1155/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1155" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1155" style="display:none" title="Cite this Page"><div class="bk_tt">Klein C, Lohmann K, Marras C, et al. Hereditary Dystonia Overview. 2003 Oct 28 [Updated 2017 Jun 22]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1155/pdf/Bookshelf_NBK1155.pdf">PDF version of this page</a> (548K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#dystonia-ov.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#dystonia-ov.Clinical_Characteristics_of" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics of Dystonia</a></li><li><a href="#dystonia-ov.Causes_of_Hereditary_Dystoni" ref="log$=inpage&amp;link_id=inpage">Causes of Hereditary Dystonia</a></li><li><a href="#dystonia-ov.NonGenetic_Causes_of_Dystoni" ref="log$=inpage&amp;link_id=inpage">Non-Genetic Causes of Dystonia</a></li><li><a href="#dystonia-ov.Evaluation_Strategy" ref="log$=inpage&amp;link_id=inpage">Evaluation Strategy</a></li><li><a href="#dystonia-ov.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#dystonia-ov.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#dystonia-ov.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#dystonia-ov.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1496522" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1496522" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301601" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Neuronal Ceroid-Lipofuscinoses</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Neuronal Ceroid-Lipofuscinoses<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mole SE, Williams RE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24501781" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Leukodystrophy Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Leukodystrophy Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Vanderver A, Tonduti D, Schiffmann R, Schmidt J, van der Knaap MS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301317" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hereditary Ataxia Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hereditary Ataxia Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bird TD. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301682" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hereditary Spastic Paraplegia Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hereditary Spastic Paraplegia Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hedera P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23447832" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Neurodegeneration with Brain Iron Accumulation Disorders Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Neurodegeneration with Brain Iron Accumulation Disorders Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gregory A, Hayflick S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301334" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301334" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0416c6dde08911691998d4">Hereditary Dystonia Overview - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Hereditary Dystonia Overview - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:11:18-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE8802A3E04150510000000000D20057&amp;ncbi_session=CE8802A3E0416C51_0210SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1155%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1155&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1155/&amp;ncbi_pagename=Hereditary Dystonia Overview - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8802A3E0416C51_0210SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>